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Abstract 
Objective: This paper aims at investigating different parameters of blood pressure 
(BP) in patients with pregnancy-induced hypertension (PIH). The research study was 
divided into two parts. In the first study, readings of BP with Cortronics 7000 
continuous BP monitor (Cor 7000) and Dinamap 1846SX were compared by 
measuring changes in BP induced by isometric exercise in pregnant women. The 
second study was the major part of this thesis. Firstly, platelet angiotensin II (ANG 
II) receptor status was investigated in healthy nonpregnant women and Chinese 
primagravidae, in which the latter were known to be at higher risk of developing PIH. 
Secondly, the cardiodynamic parameters (heart rate, cardiac output, stroke volume 
and systemic vascular resistance) in the rest sitting, left lateral and supine positions 
and during isometric handgrip exercise were measured in primagravidae at the second 
trimester. Follow-up studies were performed ten patients in the post-natal period. 
Moreover, the effects of calcium supplementation and low-dose aspirin on the ANG 
II receptor status and BP at different stages of pregnancy were investigated. 
Methods: Study one consisted of 20 pregnant Chinese women, 9 normotensive and 
11 with PIH. Simultaneous brachial artery blood pressures were recorded by Cor 
7000 and Dinamap 1846SX, in the supine position at rest and after isometric 
exercise. 
Study two consisted of 63 patients at 22-24 weeks of gestation recruited from 
the roll-over test project. Platelet ANG II binding was measured by 
radioimmunoassay. The patients were measured for cardiodynamic parameters in a 
ii 
series of position changes and in isometric exercise test whilst being continuously 
monitored by the Cor 7000 and the Bomed impedance cardiograph. 
Results: In my first study, BP measurements with the two machines were highly 
correlated (r>0.8) but the Cor 7000 tended to read about 2.5mmHg lower than the 
Dinamap. The pattern of change in MAP following isometric exercise differed 
between patients with proteinuric PIH and those who were normotensive or had only 
mild to moderate, non-proteinuric PIH. These patterns were not influenced by the 
type of sphygmomanometer or the arm used for measurement. 
In the second, platelet ANG II binding was not correlated to any of the 
cardiodynamic parameter at different positions. 
MAP but not diastolic blood pressure was significantly decreased following 
change in position from left lateral to supine position (p =0.007). However，increase 
in both diastolic blood pressure and MAP were observed in 17 out of the 59 cases. 
MAP did not rise significantly during isometric handgrip exercise but did so during 
the recovery phase (p=0.017). Diastolic pressure rose significantly during isometric 
exercise (p=0.013) but was not significantly different after 5 minutes recovery time 
(p=0.06). This was contrary to expectation of an increase and was explained by the 
positioning of the sphygmomanometer cuff on the left (lower) arm rather than the 
more usual upper arm 
Conclusions: The Cor 7000 monitor provides compatible measurements of BP to 
the Dinamap. Differential patterns of response may have a predictive value for 
proteinuric PIH. Platelet ANG II binding does no have predictive value for PIH in 
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the Chinese community that may be due to the treatment of low-dose aspirin and 
calcium supplementation in two-thirds of the patients. 
iv 
List of Abbreviations 
ACI Acceleration Index 
ANGII Angiotensin II 
AST Angiotensin II Sensitivity Test 
BP Blood Pressure 
BSA Body Surface Area 
Ca++ Calcium 
CI Cardiac Index 
CO Cardiac Output 
DBP Diastolic Blood Pressure 
DIC Disseminated Intravascular Coagulation 
EDI End Diastolic Index 
EF Ejection Fraction 
HR Heart Rate 
IC Impedance Cardiography 
ISSHP International Society for the Study ofHypertension in 
Pregnancy 
X 
IUGR Intrauterine Growth Retardation 
MAP Mean Arterial Pressure 
MAP-2 Second Trimester Mean Arterial Pressure 
P Pulse Rate 
PET Pre-eclampsia 
PFI Peak Flow Index 
PFI Peripheral Fraction Index 
PGI2 Prostacyclin 
P M Pregnancy-induced hypertension 
Fs Spearman correlation Coefficients 
RIA Radioimmunoassay 
ROT Roll-Over Test 
PRP Platelet Rich Plasma 
SGOT Serum Glutamic-Oxaloacetic Transaminase 
SEM Standard Error of the Mean 
STR Systolic Time Ratio 
SV Stroke Volume 
vi 
SI Stroke Index 
SBP Systolic Blood Pressure 
TEB Transthoracic Electrical Bioimpedance 
TFI Thoracic Fluid Index 
TPVR Total Peripheral Vascular Resistance 
TXA2 Thromboxane A2 
VET Ventricular Ejection Time 
WHO World Health Organisation 
vii 
TABLE OF CONTENTS 
Ahstract i 
List of Abbreviations iv 
Table of Contents vii 
CHAPTER 1 INTRODUCTION 
1. Definitions & Morbid implication ofPIH 
1.1. Definition ofPIH 1 
1.2. Classification 2 
1.3. Background 3 
2. Aetiology PIH 4 
2.1. Anatomy of placenta 4 
2.2. Physiology of placenta 4 
2.3. The placenta as the cause ofPIH 6 
2.4. Pathology of the placental bed 7 
3. Epidemiology ofPIH 9 
‘ viii 
3.1. Maternal risk factors 9 
3.2. Fetal risk factors 10 
3.3. Genetics o fPIH 10 
3.4. Maternal outcome 12 
3.5. Fetal outcome 13 
4. Pathophysiologic changes in PIH 14 
4.1. Important Pathophysiologic changes in PIH 14 
4.1.1. Hyperdynamic circulation 14 
4.1.2. Changes in Intravascular volume 15 
4.1.3. Loss of resistance to Angiotensin II and 
catecholamines 16 
4.1.4. Coagulation abnormalities 16 
4.1.5. Platelets 17 
4.2. Multisystem disorder in PIH 18 
4.2.1. The kidney 18 
4.2.2. The liver 19 
4.2.3. The brain and nervous system 19 
ix 
4.2.4. Cardiovascular and renin-angiotensin systems 20 
4.2.5. Placenta 21 
5. Prediction o fPIH 22 
5.1. Standard methods of antental care 22 
5.1.1 • Blood pressure increase in antenatal period 22 
5.1.2. Second Trimester Mean Arterial Pressure 23 
5.1.3. Proteinuria 25 
5.1.4. Excessive weight gain and edema 26 
5.1.5. Platelet count 27 
5.2. Vasoconstriction tests 27 
5.2.1. The Isometric Handgrip Exercise Test 27 
5.2.2. Roll-Over Test 28 
5.2.3. Infusion of Angiotensin II 31 
5.3. Biochemical tests 33 
5.3.1. Urinary Calcium excretion 33 
5.3.2. Prostacyclin & throboxane A2 33 
5.3.3. Platelet Angiotensin II receptors 34 
X 
5.4. Ultrasougographic evaluation 36 
5.4.1 • Doppler waveforms of uteroplacental circulation.... 36 
6. Prevention & treatment o fPIH 38 
6.1. Antihypertensive drugs 40 
6.2. Antithrombotic agents 40 
6.2.1. Low-dose aspirin 40 
6.3. Calcium supplementation 44 
CHAPTER 2 General Methodology 
1.1 Introduction 48 
1.2. Materials 48 
2 Studies 51 
2.1. Validation of Cor-7000 Sphygmomanometer 51 
2.1.1. Patients 51 
2.1.2. Methods 51 
2.1.3. Statistics 52 
2.1.4. Results 53 
xi 
2.2. Platelet ANGII receptor status and systemic vascular 
ft 
resistance 58 
2.2.1. Control subjects 58 
2.2.2. Patient subjects 58 
2.2.3. Platelet preparation and platelet angiotensin II binding 
site assay 60 
2.2.3.1. Statistical analysis 62 
2.2.3.2. Results 63 
2.2.4. Using impedance techniques to measurement of 
systemic vascular resistance 74 
2.2.4.1. Measurement of Cardiac Output by 
impedance cardiography 74 
2.2.4.2. Validity of transthoracic electrical 
bioimpedance technique 81 
2.2.4.3. Measurement of mean arterial pressure ... 87 
2.2.4.3.1. Experimental technique 87 
2.2.4.3.2. Statistical analysis 92 
2.2.4.4. Results 92 
xii 
2.2.4.5. Data analysis 93 
2.2.4.6. Relationship between platelet ANGII binding 
and haemodynamic indices ••••• 110 
2.2.4.7. pregnancy outcome 115 
CHAPTER 3. RESULTS 
1. Study 1 Validation of Cor 7000 sphygmomanometer 116 
2. Study 2 Platelet ANG II receptor status and systemic vascular 
resistance 118 
2.1. Platelet Angiotensin II binding Assay 118 
2.2. Limitation of the TEB technique 121 
2.3. Changes in blood pressure and other cardiovascular 
indices 122 
2.4. Relationship between Platelet ANG II binding and 
Haemodynamic indices 124 
CHAPTER 4 CONCLUSION 






1. Definitions & morbid imnlications 
1.1. Pregnancy-induced hypertension (PIH) 
Pregnancy may induce hypertension in women who are normotensive before 
pregnancy and tnay aggravate hypertension in those who were hypertensive before 
pregnancy. According to the international Society for the Study of Hypertension in 
Pregnancy (ISSHP) (Davey and MacGillivray, 1988). The diagnosis of hypertension 
in pregnancy is made by either one of the following criteria: 
1) one measurement of diastolic blood pressure equal to or greater than 110 mmHg. 
2) two consecutive measurements of diastolic blood pressure equal to or greater 
than 90 mmHg, measured four or more hours apart. 
Pre-eclampsia (PET) is a term that its often loosely applied to these patients; 
However, PET means different things to different people and can lead to confusion. 
Traditionally, it is associated with three classic clinical findings, namely hypertension, 
proteinuria and oedema (Perry et al, 1994). As proteinuria is really a measure of 
disease severity (MacGillivray, 1961) and oedema is regularly a feature of normal 
pregnancy (Thomson, et al, 1967), this term should be reserved for severe 
(proteinuric) pregnancy-induced hypertension (PIH) alone. Gestational hypertension 
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without proteinuria can be ternned mild or moderate PIH. PET is associated with 
high maternal and fetal morbidity and mortality (Ferrazzani et al, 1990; Friedman & 
Neff，1976). 
1.2. Classification 
The classification of hypertension in pregnancy is a difficult and confusing 
area. These difficulties stem from the variety of conditions which make up the 
hypertensive disorders of pregnancy, from our lack ofknowledge as to the aetiology 
of these conditions and from a lack of agreement on their nomenclature (Greer IA, 
1993). 
Hypertension in pregnancy may be grouped into one of four categories: 
1) it may antedate the pregnancy; there are women who have chronic hypertensive 
problems antedating the pregnancy. These women usually have essential 
hypertension, which often has an inherited component but has no well-defined 
underlying pathology. Less frequently the hypertension is due to a more serious 
pre-existing medical disorder, such as renal disease. 
2) it may be caused by the pregnancy itself; there are women who are normotensive 
before pregnancy and in early pregnancy who become hypertensive during 
pregnancy, becoming normotensive again within a few months of delivery. These 
women have PIH. 
3) chronic hypertensive disease may be exacerbated by PIH 
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4) much more rarely; a new medical problem may become evident, by chance 
coinciding with pregnancy, such as phaeochromocytoma or Conn's syndrome. 
Most classification systems will reflect these four situations QSfelson, 1955; 
WHO, 1987; Davey & MacGillivray，1987; Redman & Jefferies, 1988; Perry & 
Beevers, 1994). Furthermore, these classifications are essential to make the 
diagnosis consistent, to help quantify the risk to mother and fetus and to guide 
decisions regarding patient management. 
1.3. Background 
It has long been recognized that hypertensive disorders are the most common 
complication of pregnancy. Hypertension occurs in around 15 % of all pregnancies 
(Walker JJ, 1993). PIH characterizes a clinical spectrum ranging from minimal 
elevations in blood pressure to severe hypertension with multiple organ dysfunction 
unique to pregnant women. The disease complicates about 5-7% of pregnancies in 
otherwise normal women, and as many as 20-40% of pregnancies in women with 
chronic renal or vascular diseases (Scott & Worley, 1990). In developed countries 
this is one of the most prominent causes of maternal and infant morbidity and death. 
In England and Wales hypertensive diseases rank second only to pulmonary embolus 
as a cause of maternal death (TurnbulI et al 1989). 
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2. Aetiology ofPIH 
2.1. Anatomy ofPlacenta 
The human placenta at term is a discoid organ measuring approximately 20 
cm in diameter and 2 to 3 cm in thickness. It weighs approximately 500g and is 
generally located in the uterus near the fijndus. 
The fetal surface is covered by transparent amnion beneath which the fetal 
chorionic vessels course, with the arteries passing over the veins. A section through 
the placenta in situ, includes amnion, chorion, chorionic villi and intervillous spaces, 
decidual plate, and myometrium. The chorion leave does not extend over the 
placental surface; the amnion is in direct contact with the adventitial surface of the 
chorionic vessels and the chorionic plate on the fetal surface of the placenta. 
The maternal surface of placenta is divided into irregular lobes by furrows 
produced by septa consisting of fibrous tissue, with sparse vessels confined mainly to 
their bases. The broad based septa ordinarily do not reach the chorionic plate, thus 
providing only incomplete partitions. 
2.2. Physiology ofPlacenta 
1) Fetal Circulation 
Fetal blood flows to the placenta through the two umbilical arteries, which 
carry deoxygenated blood. At the junction of the umbilical cord with the placenta, 
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the umbilical vessels branch repeatedly beneath the amnion and again within the 
dividing villi, forming capillary networks in the terminal divisions. Blood, with a 
significantly higher oxygen content, returns to the fetus from the placenta through the 
single umbilical vein. The umbilical vessels that traverse the fetal surface of the 
placenta are referred to as placental surface or chorionic vessels. The two umbilical 
arteries separate at the chorionic plate and supply branches to the cotyledons. Two 
different patterns of chorionic artery branching are recognized: disperse (63%) and 
magistral (37%). In the disperse type, the pattern of distribution is that of a fine 
network of vessels that traverse from the site of insertion of the umbilical cord to the 
various cotyledons. The magistral pattern is characterized by arteries that traverse to 
the edge of the placenta without an appreciable decrease in the diameter of the vessel. 
The arteries individually supply one cotyledon as the branch turns downward to 
pierce the chorionic plate. There is a 1:1 relationship between the cotyledon arteries 
and veins. 
2) Maternal Circulation 
Fetal homeostasis is dependent on an efficient maternal placental circulation. 
The extensive efforts of investigators to define the factors regulating the flow of 
blood into and away from the intervillous space have led to important practical 
applications in obstetrics. The blood actually flows into an amorphous space lined by 
trophoblastic syncytium rather than capillary endothelium, and returns through 
maternal veins; this prevents production of arteriovenous shunts and allows blood to 
remain in contact with the villi long enough for adequate exchange. Maternal blood 
entering through the basal plate is driven by maternal arterial pressure high up toward 
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the chorionic plate before lateral dispersion occurs. After bathing the chorionic villi, 
the blood drains through venous orifices in the basal plate and enters the uterine 
veins. The maternal blood thus traverses the placenta randomly without performed 
channels, propelled by the maternal arterial pressure. 
Ramsey and Donner (1980) presented a summary of anatomical studies o f the 
uteroplacental vasculature. They noted that cytotrophoblastic elements are initially 
confined to the terminal portions of the uteroplacental arteries but later extend 
proximally. By the 16th week of pregnancy, cytotrophoblasts are found in many of 
the arteries of the inner layer of myometrium (Hamilton and Boyd 1970). Intra-
arterial accumulation of trophoblast cells may ultimately stop circulation through 
some of these vessels: The number of arterial openings into the intervillous space is 
gradually reduced by cytotrophoblastic proliferation and the walls of the more 
proximal parts of the arteries are breached by deeply penetrating trophoblast cells. 
After the 30th week, a prominent venous plexus separates the decidua basalis from 
the myometrium, which provides a plane of cleavage for separation of the placenta. 
2.3. The placenta as a cause of pregnancy induced hypertension 
It is generally accepted that the initial pathological changes of PET occur 
within the placenta and placental bed (Fox H，1987). Some factor (Factor X) had to 
be proposed to link the placental pathology and the systemic disease processes. The 
placental problems are thought to cause placental ischaemia, and this ischaemia 
releases Factor X into the circulation and causes the systemic syndrome, particularly 
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by interfering with vascular endothelium. Factor X is thought to be 
syncytiotrophoblast, shed from the microvillus membrane into the maternal 
circulation. 
2.4. Pathology of the placental bed 
Endothelial damage and dysfunction is common to all the pathological 
features ofPIH, whether in the utero-placental bed or other organs. 
In normal pregnancy, a series of physiological changes occurs in the spiral 
arteries of the placental bed as they are invaded by the cytotrophoblast (Robertson 
andKhong, 1987). This cytotrophoblastic invasion occurs in two stages: In the first 
trimester the cytotrophoblast penetrates the decidual spiral arteries and migrates 
down these vessels. This endovascular trophoblast invades the vessel wall, removing 
the endothelium, internal elastic lamina and muscular coat of the vessel, which are 
largely replaced by fibrinoid material. In the early part of the second trimester a 
second wave of cytotrophoblast invasion occurs and the endovascular trophoblast 
similarly transforms the myometerial segments of the spiral arteries and sometimes 
even the distal segments of the radial arteries (Pijnenborg et al., 1980, 1981, 1983). 
These physiological changes convert the vessels from muscular end-arteries to wide-
mouthed sinusoids, so transforming the vascular supply from a high-pressure / low-
flow system to a low-pressure / high-flow system (Moll, Kinzel and Hoberger, 1975) 
to meet the needs of the fetus and placenta. 
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In PIH the trophoblast invasion is somehow impaired: Only about one-halfto 
two-thirds o f the decidual spiral arteries undergo these physiological changes (Khong 
et al., 1986). Furthermore, the conversion of the myometrial portions of the spiral 
arteries fails to occur, even in vessels where the decidual segments have undergone 
physiological change. These findings suggest that primary invasion oftrophoblast is 
partially impaired and that the second wave fails to occur or is inhibited. This 
restriction ofphysiological change results in reduced placental blood flow (Robertson 
and Khong, 1987) which becomes more threatening as the pregnancy advances and 
the demands of the conceptus increase. Additionally, as the vessels maintain their 
muscular coats, they remain sensitive to vasomotor stimuli. The pathological 
changes seen in pre-eclatnpsia (PET) are identical to those seen in uterine growth 
retardation, again emphasising that maternal systemic sensitivity appears to be an 
important factor in the development of this syndrome. 
The abnormalities in the maternal placenta are likely to produce ischaemia of 
the fetal placenta. These include placental infarcts, patchy necrosis and intracellular 
damage of the syncytiotrophoblast, an increase in villous cytotrophoblastic cells and 
an obliterate endarteritis of the fetal stem arteries (Fox, 1988). The latter change is 
responsible for the increased vascular resistance which is readily demonstrated by 
Doppler assessment of the umbilical artery, where absent or impaired end-diastolic 
flow can be seen in some pregnancies complicated by severe PIH. 
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3. Epidemiology ofPIH 
3.1. Maternal risk factors 
Severe PIH has traditionally been regarded as a disease of primigravidae: 
MacGillivray (1958), showed that the risk of severe disease was 15 times greater in a 
first than in a second pregnancy. This study suggested that a previous pregnancy was 
protective with regard to the development of proteinuric PET. Milder forms of the 
disease are also more common in primigravidae. Even secundiparae with an affected 
first pregnancy have a lower overall incidence, which is 10 to 15 times higher than for 
secundiparae with a previously normal pregnancy (Campbell and MacGillivray 1985). 
In a further study in 1985, Campbell and MacGillivray showed that whereas a first 
trimester abortion did not protect against PET in a second pregnancy, a late 
spontaneous abortion did significantly reduce the risk of PET in a subsequent 
pregnancy, to 1.7 percent. If the first pregnancy ended after 37 weeks' gestation 
without any hypertensive complication, the incidence ofPET in the second pregnancy 
was reduced to 0.7 percent. However, if the first pregnancy was complicated by a 
low-birth weight baby (< 2.5 kg), the incidence of PET in a second pregnancy 
increased to 11.9 percent (Campbell and MacGillivray, 1985). 
An association also exists between maternal age and PIH with the incidence 
rising sharply after age 35 (Butler and Alberman, 1969). This increase may be related 
to an increased likelihood ofPIH or may be due to an increased incidence of medical 
conditions misdiagnosed as PIH. The predisposition to PET may be inherited so that 
a positive family history is a risk factor: the daughters of eclamptic women are eight 
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times more likely to have PET than would be expected. Overweight women are 
more likely to have chronic hypertension. Diabetic women are also at increased risk 
o fP IH (Howy et al., 1982). 
3.2. Fetal risk factors 
Fetal factors are associated with an increased risk ofPIH: These include twin 
pregnancies (MacGillivray, 1986), hydrops fetalis (Scott, 1952), hydatidiform moles 
(Scott, 1952), triploidy and trisomy 13 (Boyd, Lindenbaum and Redman, 1987). 
3.3. Genetics ofPIH 
Blood pressure is a complex quantitative trait that is determined by multiple 
environmental and genetic factors (Durtz and Spence; 1993). Although some simple 
Mendelian forms of high blood pressure have been described, essential hypertension 
is characterized by a complex mode of inheritance. Little is known about the manner 
in which increased blood pressure is genetically transmitted in families. Based on 
recent advances in molecular biology and statistical genetics, it has become feasible to 
search for chromosome regions that may contain genes contributing to the 
pathogenesis ofhypertension in humans. 
Today, most investigators in the field study the genetic determinants ofblood 
pressure rather than the genetics of essential hypertension. Blood pressure, like many 
other quantitative characteristics, is determined by the interaction of multiple genetic 
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and environmental factors. For example, recent linkage and association studies have 
raised the possibility that a blood pressure regulatory locus may exist in or near the 
angiotensinogen gene on chromosome. 
PIH is associated with an inherited component, (Adams and Finlayson 1961， 
Chesley, Cosgrove and Annitto 1961; Chesley, Annitto and Cosgrove 1968). 
although the precise genetic basis is not clear. In 1986, Chesley and Cooper showed 
that the disorder was inheritable and that their data were compatible with a single 
gene model, on the basis of a large family study using eclampsia as the index 
condition. In keeping with their previous suggestion that a single maternal autosomal 
recessive gene could be responsible (Cooper and Liston 1979)，a second study 
suggested that a fetal genetic component also contributed (Chesley and Cooper 
1988). As an association between eclampsia and miscarriage was found in this study, 
they concluded that there may be a genetic basis for disturbance of the normal feto-
maternal interaction in the placental bed, and this may point to an immune 
mechanism. 
Major histocompatibility complexes in the genetic mechanism of Pff l have 
been implicated by several studies (Redman et al., 1978; Redman, 1986; Kilpatrick, 
1987; Kilpatrick et al., 1987). An increased incidence of HLA DR4 has been noted 
PET women and their babies (Kilpatrick et al., 1987). Later observations were 
extended to the sisters of women with proteinuric PIH (Kilpatrick et al,. 1989). This 
study revealed that the sisters had a higher incidence of PIH than the maternity 
hospital population and that the frequency of HLA DR4 was increased in the sisters 
who developed PIH compared with sisters with normotensive pregnancy. The 
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genetic data from Copper's study were consistent with the proposal that a fetal 
component to susceptibility was involved (1988). The data ofKilpatrick et al (1989) 
were also consistent with the involvement of a single recessive gene shared by mother 
and fetus. If a single gene cause can be isolated then molecular biology may allow 
screening couples for risk ofPIH. 
3.4. Maternal outcome 
The incidence of mild/moderate PIH is difficult to establish because of the 
difficulties in diagnosis and classification previously discussed. In Campbell and 
MacGillivray's 1985 study the overall incidence of proteinuria PIH was 3 percent 
whereas the incidence of eclampsia was 0.1 percent. The incidence does not appear 
to have changed significantly over the last 30 years, having remained around 20 
percent (Campbell & MacGillivray, 1985; Hall & Campbell, 1987). 
The commonest mode of death is cerebral haemorrhage. Cerebral oedema, 
cerebral infarction, pulmonary oedema and hepatic necrosis are also primary causes 
of death, although liver damage, disseminated intravascular coagulation (DIC) and 
fluid overload are also associated with many of the deaths and are likely to be 
significant contributory factors. In addition to those deaths directly attributable to 
hypertensive complications of pregnancy, a number of deaths also occur which, 
although directly attributable to other causes such as pulmonary thrombolism, are 
associated with hypertensive complications. 
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3.5. Fetal outcome 
Severe PIH and eclampsia are associated with a poor fetal outcome due to 
growth retardation, intrauterine asphyxia and iatrogenic prematurity. Severe PIH is 
also associated with intrauterine growth retardation (IUGR) (Moore and Redman, 
1983) although mild/moderate PIH is not (Baird, Thomson and Billewicz, 1957; Low 
and Galbraith. 1974), there is also and also an association between severe Pf f l and 
neurodevelopmental disability (Taylor, 1988). The fetus is also at increased risk from 
abruption, which is approximately three times as common in severe disease as in 
normal pregnancy (Sibai et al., 1986). . 
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4. Pathophysiologic changes in PIH 
4.1 Important nathonhysiologic changes in PIH 
1) Hyperdynamic circulation 
Normal pregnancy is associated with a number of alterations in the 
cardiovascular system, which start to occur in early pregnancy (Atkins et al.，1981; 
Capeless et al., 1989). 
Cardiac output (CO) increases by around 40 percent in the first trimester and 
this is maintained throughout pregnancy (Lees et al., 1967), although it is reduced in 
the third trimester when measured in the supine position, owing to diminished venous 
return which is obstructed by the gravid uterus (Lees et al., 1967 and Ueland et at.， 
1969). In particular, when a patient during the final 8-12 week of pregnancy lies 
supine, the uterus may compress a segment o fher inferior vena cava and also of her 
aorta. Venous return to the heart, and hence cardiac output will tend to be reduced 
to an extent governed by the size of the collateral venous system. The fall in systemic 
arterial blood pressure which should result from such a drop in cardiac output, is 
countered by an increase in vasomotor tone (peripheral resistance). Cardiac output 
falls in the supine position because of the increased afterload caused by constriction 
ofblood vessels (arterioles and veins) in the uterine vascular bed (Blake et al., 1983). 
As blood pressure is determined by CO and peripheral resistance, the 
decrease in blood pressure seen in the first and second trimesters of pregnancy must 
be due to a fall in the latter. These changes occur in early pregnancy. They must 
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therefore reflect a change in systemic vascular resistance, as the uteroplacental 
circulation is not sufficiently large to account for such a reduction in peripheral 
resistance at this stage of pregnancy. 
In PIH the increase in blood pressure is the result of an increase in systemic 
vascular resistance (Ginsburg and Duncan, 1967) in the face of an unchanged CO 
occurring in the second half of pregnancy. 
In 1989 Robson et al reported that heart rate and left ventricular performance 
increased during the first trimester. Heart rate (HR) increased further during the 
second trimester during which left atrial and left ventricular end-diastolic dimensions 
(EDD) increased, suggesting an increase in venous return. Derived values of total 
peripheral vascular resistance (TPVR) fell during the first 20 weeks. 
Recent studies (Mabie WC, 1989; MacPhail, 1991 & 1992) suggest that an 
increase in maternal CO rather than increased peripheral vascular resistance is the 
most frequent haetnodynamic finding in PET. The elevation in cardiac output in 
patients with PE may start as early as 12 weeks and persist in the puerperium despite 
resolution of the hypertension (Werko; 1954). 
2) changes in intravascular volume. 
Reduced blood volume is commonly found in women with PIH, in some cases 
of severe PIH, it is not uncommon for the blood volume to be 10-20 percent less than 
non-pregnant values. As PIH occurs as a consequence of loss of vascular 
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refractoriness to vasoconstrictive agents, it is possible that in a late phase of 
vasoconstriction, blood pressure control could still be maintained, by a reduction in 
intravascular volume, at least transiently. 
3) loss of resistance to angiotensin II and catecholamines. 
ANG II is one of the most potent pressor agent known and induces rapid, 
brief rises in blood pressure when injected intravenously. It constricts arterioles in 
the mesenteric, skin, coronary, and cerebral circulations. When admiiiistered 
intravenously to an intact animal the net effect on regional blood flow varies 
according to whether local vasoconstriction or increased perfusion pressure 
predominates (Page and McCubbin, 1968). 
ANG II initiates its action on vascular smooth muscle by binding to high 
affinity receptor sites located on the cell surface (Baker et al, 1989, 1992, 1994). 
4) coagulation abnormalities. 
Coagulation abnormalities exist in a minority of patients with severe PET. 
The most serious hematological complication ofPET is the HELLP syndrome (Greer 
IA et al., 1985): hemolytic anemia, elevated liver enzymes, low platelet count 
(Pritchard, 1976). 
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PET is associated with vasoconstriction and activation of the coagulation 
system. The high fibronectin, low antithrombin III and increased P_thromboglobulin 
levels found in patients with PET are suggestive of endothelial injury, enhanced 
clotting, and increased platelet consumption (Sibai et al; 1992). It has been 
proposed the vascular endothelial damage decreases PGI2 production and activation 
of clotting and fibrinolysis, with subsequent generation of thrombin and plasma. 
Thrombin consumes antithrombin III, resulting in fibrin deposition; platelet activation 
with the release of TxA2 causes further vasospasm, platelet aggregation, and 
endothelial injury. 
One rarely sees disseminated intravascular coagulation (DIC) in women with 
PIH, and there is no good evidence that the coagulopathy causes the hypertensive 
syndrome. The routine tests for coagulation defects are essentially normal in PIH 
• 
unless complicated by full-blown DIC. 
5) platelets. 
Platelets have a pivotal role in the pathophysiology of PIH. When platelets 
are activated due to contact with the subendothelium they aggregate. Aggregation 
*' 
involves a series of morphological and functional changes. The platelet degranulates, 
releasing granule contents and serotonin, and synthesizes and releases thromboxane 
A2. 
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The platelet content of 5-hydroxytryptamine is reduced in PIH (Whigham et 
al; 1978). Platelets have also been shown to be less sensitive to the anti-aggregatory 
effects of prostacyclin in PIH (Briel et a; 1984). 
4.2, PIH as a multisystem disorder 
1) The kidney. 
A number of pathological changes, which tend to parallel the clinical situation 
in terms of severity, occur in the kidney in PIH (Spargo et al., 1959; Pollak et al., 
1960; Thomson et al., 1972; Sheehan et al., 1973). During normal pregnancy, renal 
blood flow and glomerular filtration rate increase. With development of pregnancy-
induced hypertension, renal perfusion and glomerular filtration are reduced 
(Hypertensive disorders in pregnancy, 1993). In PET, the glomerulus is diffusely 
enlarged and bloodless, due to hypertrophy of the intracapillary cells The glomeruli 
sometimes bulge and protrude into the proximal tubule, owing to swelling and 
vacuolation of the cytoplasm of the glomerular endothelial cells in the capillary loops 
(Spargo, et al, 1959). These changes are known as glomerular capillary 
endotheliosis. Capillary endotheliosis almost always presents with proteinuria. The 
• 
renal tubules are usually left intact although areas of focal necrosis and repair can be 
seen. 
In the majority of pre-eclamptic women, mild to moderately diminished 
glomerular filtration appears to result from a reduced plasma volume; plasma 
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creatinine seldom is below normal non-pregnant levels. Changes in renal function 
include a reduced glomerular filtration rate and renal plasma flow that may progress 
to renal ischemia. 
2) The liver. 
The main hepatic lesions seen in PIH are lake haemorrhages, periportal fibrin 
deposition within the lake haemorrhages, and areas of infarction and necrosis 
(Sheehan and Lynch, 1973). Numerous reports indicate that half of women with 
severe PIH have an increased semm glutamic-oxaloacetic transaminase (SGOT) 
concentration (Bonglin 1959), and serum bilirubin levels and a variety of other liver 
function tests are often abnormal (Sibai and colleagues, 1986). The underlying 
problem may be mistakenly attributed to hepatobiliary disease or other 
gastrointestinal disorders, particularly by nonobstetric physicians less familiar with the 
clinical manifestations ofPET. 
3) The brain and nervous system. 
The brain can be involved in the pathological process of PIH with eclampsia 
being one of the most extreme clinical manifestations. The pathological features that 
can occur include cerebral oedema, cerebral haemorrhage, petechial haemorrhages, 
thrombotic lesions and fibrinoid necrosis (Hibbard, 1973; Sheehan and Lynch, 1973; 
Lopez-Llera et al, 1976). 
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Vascular resistance in the brain is unaltered during normal pregnancy but is 
increased by about 50 percent in patients with PIH. In severe PIH patients may 
develop cerebral edema which is one of the most common causes of maternal death. 
Cerebral hemorrhage is best avoided by adequate control ofsevere hypertension. 
• 
i 
4) Cardiovascular and renin-angiotensin systems. 
PIH is associated with and increase in systemic vascular resistance, a 
reduction in CO and reduced cardiac preload (Wallenburg, 1988). Hypertension is an 
early feature ofPET, and is caused by increased peripheral resistance. Heart failure, 
a common cause of maternal death in severe PET, is rarely encountered in young, 
otherwise healthy women, despite the severity of PIH: Circulatory collapse most 
often occurs during labor or a few hours after delivery in elderly multiparas whose 
hypertension is difficult to control. 
In normal pregnancy there are substantial changes in the renin-angiotensin 
system. Plasma concentrations of renin, renin substrate and ANG II all increase 
throughout gestation, reaching a peak around term when they are about four times 
greater than non-pregnant levels (Weir et al,, 1975; Skinner et al., 1972; Oats et al., 
1981). Following delivery, concentrations of active renin and ANG II fall within 2 
hours, reflecting the half-life of renin in the circulation. Despite increases in plasma 
aldosterone concentration in pregnancy, these do not correlate with changes in the 
renin-angiotensin system. These systems may be dissociated, with aldosterone being 
controlled more by sodium status (Karlberg et al., 1984; Brown et al., 1988). Blood 
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pressure falls due partly to increased circulating levels o f A N G II in pregnancy. This 
reflects the well-documented vascular insensitivity to ANG II seen in normal 
pregnancy, which is maximal in the second trimester then slowly returns towards the 
normal non-pregnant situation.(Abdul-Karim and Assali, 1961; TaIledoet al., 1968; 
Gant et al., 1973). 
The increased sensitivity to ANG II can be seen in isolated resistance vessels 
of women with PIH and may be due to increased ANG II receptors and reduced 
production of vasodilator prostaglandins. 
5) Placenta. 
Many pregnancies complicated by PET show evidence of inadequate maternal 
vascular response to placentation, which includes failure of normal trophoblastic 
invasion of spiral arteries (Khong et al., 1986). The combination of vasospasm and 
initial atherosis leads to a reduction in intervillous perfusion, the main cause of 
perinatal morbidity and mortality associated with PET. The placenta may fail to 
grow properly and may remain abnormally small, or there may be reduced function in 
a normally developed placenta because of decreased blood flow. Both conditions are 
associated with fetal growth retardation. The risk of placental abruption is also 
increased, depending on the severity of the disease. 
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5. Prediction ofPIH 
During the past two decades, a major research effort has been made into 
predictive tests for PIH. The true diagnosis and therefore the classification may be 
evident only retrospectively, several weeks or even months after the pregnancy is 
completed. This may be satisfactory for the epidemiologist, but it is wholly 
unsatisfactory for the clinician who, during pregnancy, is faced with the problem of 
preventing PIH or at least making the diagnosis sufficiently early in its natural history 
to prevent morbidity and mortality. 
Over 100 clinical, physiological and biochemical tests have been suggested as 
predictive of PIH, in keeping with the legion of possible aetiologies that have been 
proposed. 
5.1. Standard methods of antenatal care 
5.1.1. Blood pressure increase in antenatal period 
Antenatal visits are conventionally arranged monthly between 20 and 24 
weeks, biweekly up to 36 weeks, and weekly thereafter until delivery. 
Blood pressure 
For methods based on blood pressure measurement to be effective, increased 
uniformity in blood pressure measurement recordings is necessary. 
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A prospective study of blood pressure in pregnancy women was reported by 
Moutquin et al (1985). The investigators used an automatic oscillometric 
sphygmomanometer and started their blood pressure readings between 9 and 12 
weeks' gestation. A total of 7800 blood pressure readings were obtained at 4 week 
intervals. Among 734 initially normotensive nulliparous women., PET (blood 
pressure > 135/85 mm Hg, edema, or proteinuria after 20 weeks) developed in 46 
(6.3%). The sensitivity for predicting PET early in pregnancy (9 to 20 weeks) on 
the basis of the occurrence of a diastolic blood pressure o f > 80 mm Hg was 32% to 
46%; on the basis o f > 85 mm Hg it was 16% to 31%, with specificities o f84% to 91 
% and 93% to 97%, respectively. The data revealed that a majority of pregnant 
women who remained normotensive during pregnancy had a diastolic blood pressure 
of great than 75 mm Hg before 20 weeks' gestation. The sensitivity ofusing an 80 to 
85 mm Hg diastolic blood pressure cutoff level in the first half of pregnancy as a test 
for the later occurrence ofPET was poor. The predictive value ofaposit ive test was 
of the order of 20 % to 30 %, but the predictive value of a negative test was 
approximately 95%. 
I 
5.1.2 Second Trimester Mean Arterial Pressure (MAP-2) 
In the 1960s and early 1970s, screening of patients by measurement of mean 
arterial blood pressure (MAP-2) in the second trimester became popular. 
Blood pressure normally falls at the beginning of pregnancy and reaches its 
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recordings as a predictive test for PET is based on study by Page and Christianson 
(1976), who presented data on the outcome of pregnancy on the basis of a 
prospective study of 14,833 single births. They incorporated over a thousand women 
of mixed parity during the fifth and sixth months at 20 to 24 weeks of gestation. 
They found that when the average second trimester (18 to 26 weeks of gestation) 
mean arterial pressure was >90 mmHg there was a significant increase in the 
frequency of PET, fetal growth retardation, and still birth. There was a steady 
progression in the incidence of the disease with each 5 mmHg increment in mid-
trimester MAP. A mid-trimester MAP >90 mmHg increased the risk of developing 
PET by over three-fold. On this basis, an average MAP-2 value o f85 or 90 mmHg in 
the second trimester has been used by several investigators to predict the later 
occurrence ofPET. 
When this method was introduced into clinical practice it failed to achieve this 
promised, predictive performance having a high false positive rate (96%). This error 
probably arose due to differences in patient position and inadequate time for rest 
prior to measurement resulting in higher blood pressure values. Elevated MAP-2 is a 
good predictor of gestational hypertension but is a poor predictor o f P E T (Sanderlin 
et al, 1987). The general impression is that a pregnant women with a diastolic blood 
pressure of >70 mm Hg, or a mean arterial pressure of about >80 mm Hg in the 
I second trimester runs a small risk of having PET later in pregnancy. Chesley and 
I 
I Sibai (1988) stated that “if an increased second-trimester MAP level predicts 
I anything, it is transient hypertension rather than pre-eclampsia-eclampsia." Recent 
j work in 1993 by Conde-Agudelo et al reported that, patterns of mean arterial 
I 
.f 
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pressure throughout pregnancy were different between women who developed PET 
(proteinuric PIH) and women who developed gestational hypertension (non-
proteinuric PIH). Their results, using receiver operator characteristic curves, showed 
that MAP-2 had a better predictive capacity for gestational hypertension than for 
PET, supporting Chesley & Sibai (1988). The sensitivity of MAP-2 for predicting 
PET ranges between 39% and 48%，and for prediction of gestational hypertension 
from 72% to 92%. Specificities for both groups were moderate (60% to 86%). 
Positive predictive values were low for both groups (5% to 33%). 
Rogers et al (1994) have shown that if MAP-2 is measured in the left lateral 
position rather than the supine position that this predictive pattern is reversed, MAP-
2 predicting proteinuric PIH better than non-proteinuric PIH. It has a high negative 
predictive value, enabling a significant proportion of patients to be effectively 
screened out as having no risk. 
5.1.3. Proteinuria 
I ！ 
I Proteinuria is much easier to quantify than hypertension. Urinary protein 
excretion normally increases in pregnancy, and may occasionally rise to 200 mg!24 h 
urine collection. The development of a radioimmunoassay (RIA) for albumin has 
made it possible to detect microalbuminuria in patients who have not developed 
proteinuria as demonstrated by clinical methods. 
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In women who become eclamptic, the presence of proteinuria is even more 
strongly associated with perinatal mortality (Nelson, 1955). The accepted threshold 
for significant proteinuria in pregnancy is 0.3g/24 hours (Davey and MacGillivray, 
1987). The ‘dipstick, test is used to screen for proteinuria in the clinical situation and 
quantification of the level of proteinuria is performed by a formal 24 hours collection 
in those cases screening positive. Using such test sticks a trace of protein 
corresponds to approximately O.lg/l; 1 + to 0.3gy l^; 2 + to l.Og/l; 3 + to 3.0gy^ I and 4 + 
to lO.Og/1 (Davey & MacGillvray; 1987). They have also suggested that proteinuria 
should be classed as severe if there are > 3.0g/l protein in 24 hours collection. 
Proteinuria is extremely valuable as a prognostic sign in PET. Frequent 
monitoring of the amount of protein excreted in the urine should be a part of the 
evaluation of these patients. 
5.1.4. Excessive weight gain and Oedema 
Oedema is included in the classic definition of PET. Oedema of the lower 
j limbs is commonly seen at routine clinical examination in late pregnancy. . Large 
increases in body weight as well as oedema of hands, face, or both are common in 
normal pregnancy. When pregnancy is complicated by hypertension the incidence is 
considerably higher. Robertson (1971) suggested that leg volume increases by only 
500-600 ml, even in women with clinical oedema. Pregnant women with PET may 
exhibit a rapid increase in weight (Thomson et al., 1967). However, severe PET and 
eclampsia can occur without oedema (Sibai et al., 1981). There is no evidence to 
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indicate that measures limiting weight gain during pregnancy, such as the use of low-
salt diet or diuretics, prevents the development ofPET. 
5.1.5. Platelet count 
The platelet count also falls in PET and is often and early feature occurring in 
the second trimester (Redman et al., 1978). Pritchard et al (1976), found 26% o f 9 1 
eclamptic patients to have platelet counts below 150,000; 17% had platelet counts 
below 100,000; and 3% had platelet counts below 50,000. 
5.2. Vasoconstriction tests 
5.2.1. The Isometric Handgrip Exercise Test 
The isometric handgrip exercise is known to increase systemic vascular 
resistance in healthy adults (Lind et al 1967). Degani et al (1985), reported the use 
of an isometric exercise test for prediction ofPIH. They proposed the diastolic blood 
'丨 
pressure response to an isometric handgrip exercise test might reflect vascular 
reactivity in pregnant women, and thus might be used to detect vascular hyperactivity 
and to predict PET. The patients compressed an inflated sphygmomanometer cuff 
for a 3 minutes period at maximal and then at 50% of maximal voluntary contraction, 
if the diastolic blood pressure increased by 20mmHg or more the test was considered 
to be positive. A sensitivity of81% and a specificity of96.5% for predictor PET was 
observed. The positive predictive value was 81%, and the negative predictive value 
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was 93%, with an incidence o f P E T of 16%. This test performed much better than 
the supine pressor test suggested by Gant et al (1974). The hand-grip test is not 
affected by position changes and is safe and easily performed. Isometric handgrip 
exercise has seen shown to raise systolic, diastolic, and mean arterial pressure 
markedly with only moderate increases in HR and CO. In a study of 200 women 
with mixed parity, Marya et al (1988) reported a sensitivity of 54% and a specificity 
of 98%, positive predictive value 79%, and negative predictive value 93% (incidence 
of PET, 14%). However, the authors did not report the definitions that were used 
for diagnosing PET. In conclusion, the isometric handgrip exercise test appears to be 
sensitive, specific, and simple, but further evaluation is necessary to determine the 
role of the technique in screening. 
5.2.2. Roll-over Test (ROT) 
The roll-over test (ROT) or supine pressor test was first descried by Gant et 
al in 1974. who noted differences in the changes in arterial pressure on turning from 
the left lateral to the supine position; defining a positive test where there was an 
increase of>20 mmHg in the diastolic blood pressure. Pregnancy outcome was given 
• ,_
；： for only 38 of the 50 women studied; apparently 12 had not completed their 
I % 
k 




i developed in 15. Of22 women with a negative ROT test 20 remained normotensive. 
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subjects studied were young black teenagers of low socio-economic group, and there 
are problems in relating the results to other populations. 
Subsequent reports have indicated that the test is less satisfactory, with a false 
positive rate of 67%, suggesting that the ROT is oflittle clinical value. Most authors 
(Gusdon et al, 1977; Marshall and Newman, 1977) reporting studies of ROT, with 
only a few exceptions, fail to identify the arm used to report blood pressure. In 1977, 
Marshall and Newman reported a study of 100 primigravid women who were 
subjected to the ROT in the second trimester of pregnancy. To establish a baseline 
diastolic blood pressure, the patient was placed in the left lateral recumbent position 
and the blood pressure was measured at 5 minutes and again at 15 minutes. The 
subject was then turned to the supine position and the blood pressure was measured 
immediately and 5 minutes later with the patient still supine. An increase in diastolic 
pressure o f20 mmHg or more was considered a positive roll-over test. 25 of the 100 
women had a positive test, of which 13 women developed PET requiring magnesium 
sulfate therapy, 8 women had transient hypertension during labor requiring no 
therapy and 4 women had no evidence of hypertension during pregnancy. The false 
positive rate was 16%. 75 women had a negative ROT of which 7 were false 
j negatives. In the same year, Gusdon et al, compared 60 primigravid with 60 
5 、 i 
j multigravid patients, using ROT for prediction ofPIH: only 50% of the primigravid 
1 % 
I 
patients showing positive results for ROT finally developed PIH and 93% of these 
patients showing negative results for ROT did not develop PIH. Thus the sensitivity 
and specificity of this test in primigravid patients were 77% and 79% respectively. On 
the other hand, in multigravid patients, only 25% of women who had positive ROT 
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test results developed PIH and 94% of the negative tests accurately predicted the 
non-development of PIH. 
Supine pressor tests have been reported by other investigators (Karbhari et 
al.，1977; Phelan et al., 1977; Thompson and Mueller-Heuback, 1978; Kuntz et al., 
1980; Andersen et al., 1980). They reported sensitivities ranging from 66 to 78% on 
single tests between 28 and 32 weeks of gestation using auscultation for the 
measurement of diastolic blood pressure. The reasons for the higher sensitivity o f the 
ROT in these studies are not clear, however, some patients have unusually low 
diastolic blood pressures in left lateral position ( <45 mm Hg )，creating a false 
positive result when the value is compared with the reading in the supine position. An 
artefactual rise in diastolic blood pressure might be expected when the patient rolls 
from the left lateral position to supine position, as the position of the 
sphygmomanometer cuff relative to the heart will be altered. (Dekker et al., 1990) In 
summary, the results of the roll-over test are highly variable among different 
investigators, and there is poor reproducibility in the same patient. Studies in the 
literature report sensitivities varying between 0% and 93%, specificities between 54% 
and 91%, and false positive results up to 90%. 
Although the results of investigation suggest that the ROT is not a reliable 
screening test for PIH in clinical practice, it has gained some popularity because ofi ts 
simplicity. However, it may be useful, in combination with MAP-2, to screen 
patients for study purposes. 
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5.2.3» Infusion of Angiotensin II 
The Angiotensin sensitivity test (AST) is useless in clinical practice because of 
its complexity, but it is useful for research purposes because it can be done in early 
pregnancy and has a high predictive value (Morris et al, 1978; Oney et al, 1982; 
Nakamura et al, 1986;). 
The ANG II sensitivity test is one of the better predictors of PET. Women 
with PIH are characterized by relatively greater blood pressure sensitivity to 
exogenous ANG II than normotensive pregnant women (Gant et al., 1987). 
Gant et al (1973) showed that patients destined to develop Pf f l could be 
identified between 28 and 32 weeks gestation by an increase in sensitivity of the 
pressor response to an infusion of ANG II which normally declines during pregnancy. 
They reported that nulliparous women who later developed hypertension in the same 
pregnancy, showed an increased vascular sensitivity to infused ANG II as early as 18 
to 22 weeks of gestation. They noted that the vasoactive octapeptide ANG II 
elicited an atypical vasopressor response in some apparently normal, healthy, 
pregnant, nulliparous, teen-age patients. Their series contained 192 patients, between 
13 and 17 years old. These patients appeared to be highly vasoreactive to small 
infusions of the drug; 91% of the subjects who needed more than 8 ng of ANG 
IL^g/min to elicit an increased in diastolic blood pressure of at least 20 mmHg 
remained normotensive throughout the pregnancy. 103 patients remained 
normotensive and 50 subsequently developed PET in the third trimester. 13 of 103 
women who had an effective pressor dose of < 8 ng/kg/min. Nine of 10 such patients 
‘ 
"1 
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subsequently developed PIH. There are problems in relating the results of Gant et al 
to other populations. Specifically, they found that patients requiring at least one 
occasion developed PIH. The other reasons, PIH in the Dallas population as 37.5%, 
and the youth and lower socio-economic status of the Afro-American population, as 
well as the tendency of Negroes to hypertension may have been predisposing factors 
in the etiology o fPIH and PET. 
Oney & Kaulhausen (1982) investigated the predictive value of the ANG II 
sensitivity test in the early diagnosis ofPIH. They found a high false-positive rate of 
approximately 50 percent. Similar results were obtained by Nakamura and Dekker. 
(1990) The AST is regarded as one of the best predictors of whether P M will 
develop later in pregnancy (Wallenburg et al, 1986). 
The AST is a rather complicated and time-consuming procedure, which may 
be the reason that its validity in prediction PET has been subsequently assessed in 




I f |：1 
Chapter I Introduction 33 
5.3. Biochemical tests 
5.3.1. Urinary calcium excretion 
Urinary calcium excretion is lower in women with PET when compared to 
normotensive pregnant women. Urinary protein excretion normally increases in 
pregnancy (Wright et al, 1987; Cheung et al, 1989) and may occasionally rise to 200 
mg per 24-hour urine collection. Such as evaluated the value of microalbuminuria 
and the calcium/creatinine ratio (Rodriguez et al 1988, Calcium/creatinine ratio an 
microalbuminuria in the prediction of PE) as predictive tests. They studied 88 
normotensive women of mixed parity at 24 to 32 week of gestation, by using values 
of less than 0.04^ig/ml and greater than 11 jLig/ml as positive test results for 
Calcium/creatinine and albumin values, respectively. The calcium-creatinine ratio 
outperformed measurement of albuminuria, with a false-positive rate o f 3 6 % and a 
false-negative rate of 4%. Baker et al (1994) have also reported the use of urinary-
albumin-creatinine ratios and calcium-creatinine ratios as screening tests for PIH. 
However, this study suggested an increase urinary creatinine concentration created as 
early as 19 weeks of gestation in patients who subsequently developed PM. 
I i 
5.3.2. Prostacyclin and throboxane A2 
Prostacyclin (PGI2) is known to cause vasorelaxation and inhibit platelet 
aggregation by receptor-mediated mechanisms (Frolich JC., 1990). Whilst cyclic 
adenosine monophosphate (cAMP) is known to act as a second messenger for 
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platelet aggregation, vasorelaxation by hyperpolarization has been described only 
recently and may provide an explanation, in addition to stimulation of cAMP, for the 
PGI2 mechanism of action on blood vessels. 
The production o fPGI2 and TxA2 is imbalance in patients who develop PET; 
prostacyclin production is decreased, and thromboxane production is increased. 
5.3.3. Platelet angiotensin IT receptors 
Whigham et al. (1978), using platelet-rich plasma, found that platelet 
aggregation induced by a wide variety of aggregating agents was unchanged in 
normal pregnancy, but most other workers have suggested that platelets are more 
active. Increased adrenaline-induced platelet aggregation has been described at 
various gestations (Yamazaki et al,. 1979; Leuschen et al., 1986). 
Measurement of platelet ANG II binding is a relatively straight forward assay, 
and can be performed using a single venous blood sample of approximately 20 ml. 
Platelet ANG II binding can be used to indicate platelet ANG II receptor number. 
V 
This assay was firstly described by Ding in 1984, who found that essential 
1^ 
S hypertension is not a associated with altered levels of platelet ANG II binding in 
nonpregnant subjects. Later, Baker et al 1990，reported the same assay, in 
normotensive primigravidae: platelet ANG II binding was found to fall in pregnancy, 
with significantly lower levels of platelet ANG II binding in first trimester patients 
when compared with nonpregnant women. In contrast, significantly higher levels of 
platelet ANG 11 binding have been found in women with established PET as 
) 
compared to normotensive primigravidae (Baker et al.，1992). Platelet ANG II 
ff' 
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binding in patients who subsequently developed PIH was sixfold higher than in the 
patients who remained normotensive (p<0.001). 
In pregnancy, levels of platelet ANG II binding have been found to mirror 
changes in ANG II pressor sensitivity, with decreased binding in normotensive 
pregnancy and increased binding in pregnancies complicated by gestational 
hypertension (Baker et al; 1991). Measurement of platelet ANG II binding has been 
suggested as a more acceptable screening test for gestational hypertension than the 
invasive AST. 
Platelets share various characteristics with vascular smooth muscle cells and 
are increasingly being used as readily accessible models for smooth muscle cells. 
Platelet ANG II receptors in prediction o f P E T were studied by Broughton-Pipkin et 
al., (1991). This study measured platelet ANG II receptors in normotensive and 
hypertensive pregnancies. This study showed that a physiologic fall in platelet ANG 
II binding occurs in early pregnancy (5-8 weeks' gestation). It was found that platelet 
ANG II receptors are increased in PET，probably as an expression of the altered 
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5.4. Doppler ultrasonography 
5.4.1. Doppler waveforms of uteroplacental circulation 
Doppler ultrasonographic systems have made it possible to study the 
perfusion ofdeep-lying vessels such as the uterine vasculature (Campbell et al, 1983， 
1986). Because of errors in the measurement of volume flow, most emphasis has 
been put on the quantitative examination of flow velocity waveforms. The velocity 
waveforms in the branches of the uterine arteries in normal pregnancy show an 
increase in end-diastolic flow velocity between 14 and 20 weeks. 
There are numerous reports (Hume et al, 1990) describing the use of 
uteroplacental flow velocity waveforms (FVWs) in the prediction, diagnosis, and 
management ofPET. 
In their first study, Campbell et al (1986) reported that measurements of 
uteroplacental FVWs at 16 to 18 weeks gestation yielded a useful screening test to 
predict the future development of PIH, fetal growth retardation and fetal asphyxia. 
They observed arcuate artery waveform patterns with reduced end-diastolic velocities 
suggestive of an elevated uteroplacental vascular resistance in 14 o f 3 1 patients with 
I complicated pregnancies. Of the 17 patients with normal arcuate artery flow velocity 
i 
j waveforms, only four developed PET, and six of the fetuses were growth retarded. 
k ！ 
！ They noted that an abnormal uteroplacental artery Doppler finding at 16 to 18 weeks 
predicted 64 % of the hypertensive pregnancies. In their results, a test to predict 
I PET or IUGR sensitivity was 68%, and specificity was 69%. The predictive value of 
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Adruini et aI (1987) in 64 high-risk pregnancies studied at 18 to 20 weeks gestation: 
The positive predictive value was 70%, negative predictive value 80%, specificity 
84%, and sensitivity 64%. 
Fleischer et al (1986) studied women with hypertensive disorders of 
pregnancy. They found that whether systolic to diastolic ratio (S/D) exceeded 2.6 
and there was a notch in the uterine artery FVW, then the pregnancy was commonly 
complicated by either poor perinatal outcome or PET. The positive predictive value 
was 93% and negative predictive value was 91%. 
Doppler flow studies of the uteroplacental circulation (Sheppard et al, 1981) 
are very suitable for selecting patients for therapeutic intervention to reduce the 
incidence of PET and its complications (fetal growth retardation) (Arduini et al., 
1987; Steel et al., 1988; 1990). 
«• 4 
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6. Prevention and treatment ofPIH. 
Prevention of PIH disorders would mean a significant step forward in 
prenatal care. The general term prevention may have three different connotations; 
Primary prevention, secondary prevention and tertiary prevention. 
1) primary prevention means averting the occurrence of a disease. 
2) secondary prevention implies breaking off the disease process 
hefore the emergence of clhiically recognizable disease. 
3) tertiary prevention means prevention of complications caused by 
the disease processes. 
Hypertensive disorders of pregnancy constitute the most common 
complication of pregnancy. Because the aetiology of PIH is yet unknown, primary 
prevention is not feasible at this moment, and secondary prevention is the focus of 
attention, using low dose aspirin and calcium supplementation. 
Prevention not only requires knowledge of pathophysiologic mechanisms of 
disease, but also availability of methods of early detection. 
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Prevention ofPET: 
Since PET begins with a placental implantation defect; it is truly impossible to 
prevent, but for those patients predisposed to developing PET the more severe forms 
of disease may be modified. 
Historically the failures of prevention include diuretics and diet. Bed rest is 
the only from of therapy that increases uterine blood flow and promotes fetal well-
being. Additionally, we know that antihypertensive drugs, especially P-blockers, do 
not prevent the occurrence of PET in the patient who has chronic hypertension. 
Methods that have been used to prevent PET include: 
Aritihypertensive drugs including diuretics 
Afiiiihrombotic agents 
a) low-dose aspirin 
b) dipyridamole 
c) combination low-dose aspirin and dipyridamole 
Nu1ri1iona1 supplementalion with 
\ 
I a) High-protein, low-salt diet 
b) Calcium 
c) Magnesium 
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d) Fish and evening primrose oil 
6.1. Antihypertensive drugs 
PIH is a curable form of hypertension; delivery will remove the disease. The 
philosophy of treatment is to protect the mother from the effects of hypertension, 
such as cerebrovascular haemorrhage and eclampsia in severe disease, and to attempt 
to reduce the disease progression and prolong the pregnancy where this is desirable, 
so reducing the risks of iatrogenic prematurity. Antihypertensive agents are 
increasingly such as methyldopa or labetalol being used in the treatment of PIH to 
relax vascular smooth muscle. This approach is based on the premise that early 
treatment of hypertension may forestall the appearance of other manifestations of 
PET. However, the placental, renal, hepatic, and homeostatic features o f P E T do not 
appear to be a direct consequence of elevated blood pressure. 
6.2. Antithrombotic agents 
6.2.1. Low-dose aspirin 
Acetylsalicylic acid (aspirin) is the most practicable and effective agent 
available at present for clinical use as anti-platelet therapy (Beaufils et al, 1985). It 
has been used successHilly as an anti-platelet agent in the non-pregnant situation 
where it has been effective in the secondary prevention of myocardial infraction and 
i -
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transient ischaemic attacks. More recently it has been used successfully in the 
prevention o fP IH and IUGR (McParland et al, 1990). 
As severe PIH appears to originate from endothelial cell dysfunction 
associated with platelet disturbances therapy directed at correcting the imbalance in 
PGI2/TXA2 ratio may prevent, or at least retard the progression of the disease. 
Based on this reasoning, investigations into the beneficial effects of Iow-dose aspirin 
have been prominent in the past decade. 
Aspirin inhibits the enzyme cyclooxygenase which is essential for the synthesis 
of prostaglalndins such as thromboxane (TXA2) and prostacyclin (PGI2). Low-dose 
aspirin selectively inhibits platelet TXA2 release but does not effect endothelial cell 
production 0fPGI2 . It is on this basis that recent clinical trials have focused on the 
use oflow-dose aspirin as a preventative agent. 
Low-dose aspirin is not curative, but is essentially a preventive treatment, 
which in order to be effective should be started weeks before clinical signs of PET 
are present. Goodlin et al in 1978 were one of the first groups to report a beneficial 
effect of aspirin in pregnancy. 
In preeclamptic patients, there is an imbalance between PGI2 and TXA2; PGI2 
synthesis is decreased, and TXA2 production is increased, leading to vasoconstriction 
i' 
i. 
^ and platelet aggregation. The absence of the normal stimulation of the renin-
i'. 
•�: 
angiotensin system, despite significant hypovolemia, and the increased vascular 
sensitivity to ANG II and norepinephrine can be explained by a single mechanism: 
endothelial cell injury causing a deficiency in production and activity of vasodilator 
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prostaglandins. This may be the cause of the selective platelet destruction， 
sometimes accompanied by microangiopathic hemolysis, and the reduced 
uteroplacental blood flow, arterial thrombosis, and placental infarction (Dekker, 
1989). Maternal prostacyclin-thromboxane imbalance, important in the pathogenesis 
of gestational hypertension, is corrected by low-dose aspirin treatment (Schiff et al, 
1989). 
Low-dose aspirin may restore PGI2 and TXA2 balance, it acts by irreversibly 
inhibiting cyclo-oxygenase, which is required for prostacyclin and TXA2 production; 
it also reduces platelet activation. TXA2 is produced primarily by the platelets, and is 
a powerful vasoconstrictor and promoter of platelet aggregation. PGI2 is produced in 
the vascular endothelium, is a powerful vasodilator because of its concomitant effect 
on vessel-wall cyclooxygenase and inhibits platelet aggregation. 20 to 80 mg of 
aspirin per day does not affect duration of pregnancy and labor or produce significant 
neonatal side effects. 
Several randomized trials have reached similar conclusions: low-dose aspirin 
reduces the risk ofPET, prolongs gestation, and increases birth weight without major 
side effects in the mother and newborn. 
The first reported prospective clinic trial using low-dose aspirin to prevent 
PET was by Beaufils in 1985, followed closely by that of Wallenburg et al., (1986). 
Both studies noted an absence of any maternal and neonatal haem'orrhagic 
complications or of neonatal cardiovascular problems. Wallenburg and co-workers 
selected 46 primigravid women at risk of PIH for randomization into a double-blind 
{ i 
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placebo-controlled study of aspirin (60 mg) versus placebo. Only two o f 2 3 women 
assigned aspirin developed mild PIH whereas 12 of the 23 women treated with 
placebo developed pre-eclatnpsia or eclampsia. The selection was based on screening 
207 women with ANG II infusion test at 28 weeks' gestation. A recent study by 
SchifFet al (1989), used the roll-over test to identify their at risk population. A total 
o f791 high risk women were screened between 28 and 29 weeks. The incidence of 
PET was significantly reduced to 2.9%. McParland et al (1990) utilized Doppler 
waveforms of the uteroplacental circulation at 24 weeks to identify a high risk group. 
Altogether 100 patients were identified and were randomized to placebo or aspirin 
(75 mg/day). There was a significant reduction in the incidence of proteinuric 
hypertension and hypertension occurring before 37 weeks. Despite these positive 
results, using a variety of indices to indicate high risk, including obstetric history, 
Doppler studies of the utero-placental circulation, the ATS and the supine pressor 
test, many researchers remain skeptical concerning the beneficial effects of low-dose 
.. 
aspirin because of the limited size of these studies. 
In 1993, other studies were published by Viinikka et al., and Parazzini et al., 
they used low-dose aspirin in prevention and treatment of IUGR and PIH. In their 
results, aspirin did not prevent maternal hypertension, but improved fetal 
haemodynamic performance and reduced the need of intensive neonatal care. 
It is probable that low-dose aspirin will not be effective in preventing all cases 
of proteinuric PIH. The recent CLASP (Lancet; 1994) trial was the largest o f the 5 
trials and has thrown some doubt on the effectiveness of low-dose aspirin in 
prevention of PIH. The Collaborative Group concluded that routine prophylactic or 
1 
\ 
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therapeutic use oflow-dose aspirin in all women at increased risk o f P f f l or IUGR is 
not supported, but may be justified in women judged to be especially liable to early-
onset PET, severe enough to need very preterm delivery. 
Large clinical trials are underway all over the world to assess the safety and 
effectiveness of low-dose aspirin in preventing PET and its complications (such as 
fetal growth retardation). Dekker et al stated in 1993，“until large clinical studies 
have been completed, it would remain unclear whether antiplatelet therapy, such as 
low-dose aspirin, should be adopted for the prevention of either PET of fetal growth 
retardation." 
6.3. Calcium supplementation 
Several epidemiological studies (Marcoux et al. 1991) and a few clinical trials 
have suggested using calcium supplementation in PIH. It has been shown in 
epidemiological studies that there is an inverse association between calcium intake 
and maternal blood pressure and the incidence of pre-eclampsia and eclampsia 
(Repke, 1991). 
Low dietary intake of calcium will stimulate plasma renin activity and 
parathyroid hormone secretion, which increases the intracellular calcium in vascular 
smooth muscle (Belizan et al, 1988), and leads to vasoconstriction. By a similar 
mechanism, calcium supplementation can reduce uterine smooth muscle contractility 
and prevent preterm labour and delivery (Villar & Repke 1990). Correction of 
！ 
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dietary calcium deficiency may have a beneficial effect on blood pressure. Calcium 
supplementation during pregnancy has been shown to reduce the sensitivity ofvessels 
to ANG II (Kawasaki et al, 1990). They compared pregnancy outcome in 22 women 
given calcium supplementation (600 mg /day) from 20 weeks 30 followed by 600 mg 
twice daily until delivery, to the outcome in 72 women who did not receive such 
supplementation, this study decreased vascular sensitivity and reduced the incidence 
o f P E T from 21.2% in non-supplemented patients to 4.5% in those patients who took 
calcium. The authors concluded that oral calcium supplementation can prevent the 
development ofPET. 
In some experimental models ofhypertension, dietary calcium may alter blood 
pressure by changing the metabolism of other electrolytes. Supplemental dietary 
calcium is associated with a reduction in membrane permeability and intracellular 
calcium, and increased Ca^^-ATPase, Na^-ATPase and K^-ATPase in vascular 
smooth muscle, which is dependent on extracellular calcium ions for activation of its 
contractile elements. The use of calcium supplementation to prevent PET is 
controversial. Calcium supplementation reduces blood pressure in pregnant women 
with a low calcium intake, but this antihypertensive effect is comparable with its 
effects in essential hypertension. However, high calcium intake is may influence cell 
membrane calcium channels, particularly those controlled by hormones, leading to a 
reduction in intracellular ionised calcium (Marcoux et al, 1991). 
Dietary supplementation with 2 g of calcium daily after 15 weeks of gestation 
has been shown to decrease the incidence of PET but it will increase the degree of 
hypercalciuria and the danger of renal calculi. 
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Calcium supplementation reduces blood pressure in pregnant women with a 
low calcium intake, but this anti-hypertensive effect is comparable with its effects in 
non-pregnant hypertension. Calcium supplementation in three placebo controlled 
trials (Villar et al 1987, Kawasaki et al 1990, Villar & Repke 1990) significantly 
reduced blood pressure, but reductions in the incidence of proteinuric PIH did not 
reach statistical significance. Belizan et al (1991), in a controlled, double blind, trial 
on 1194 nulliparous women, managed to achieve a significant reduction in PIH from 
14.8% in the placebo group to 9.8% in the supplemented group (p=0.01). However, 
on sub-dividing patients according to urinary calcium:creatinine ratio at the time of 
randomization, they discovered that this treatment effect only existed amongst those 
deemed to have low baseline ratios. 
It is probable that reductions in PIH incidence following calcium 
supplementation would not be demonstrable in women with a normal calcium intake, 
i.e. women in western, developed countries, who follow the normal recommendations 
for intake of dairy products during pregnancy. However in Asian countries, even in 
Hong Kong where nutrition is generally good, the intake of dairy products tends to 
be low. 
Previous studies have suggested that increased dietary calcium is associated 
with a decreased occurrence of PIH. In the United States the National Institute of 
Health has initiated a large multicentre prospective study on the effects of calcium 
supplementation in pregnant women with a normal diet, in order to asses its value in 
the prevention of PIH and PET, and the potential adverse effects associated with its 
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use. Because calcium supplementation is easy and cheap it may be of particular 
importance in developing countries where dietary calcium deficiency is commer. 
• • 
�» 




1. General methodology： 
1.1 Introduction. 
Two studies were performed as part of this thesis. The main study compares 
platelet angiotensin I I (ANG II) receptor status with resting, left lateral and supine 
systemic vascular resistance measurements and the changes in these measurements, 
followed by isometric handgrip exercise. This study was performed in non-pregnant 
subjects and in pregnant subjects in the second trimester of pregnancy. A second 
examination was performed in the early third trimester and a follow up study in the 
post-natal period. 
As a new oscilIometric sphygmomanometer was introduced for continuous 
measurement of MAP, a preliminary study was necessary to validate this machine 
against the better established Dinamap. 
1.2 Materials: 
Calcium supplements (Caltrate 600; American Cyanamid Company, Pearl 
River, New York), were donated by Zuellig Pharma Limited, Hong Kong. 
•. 
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Materna (prenatal vitamin & mineral tablets) was also obtained from Zuellig 
Pharma Limited, Hong Kong, who also kindly sponsored the first year ofthe research 
project. 
Aspirin (80 mg). 
Dinamap 1846SX oscillometric sphygmomanometer (Critikon Inc., Tampa, 
Florida). 
Cor 7000 oscillometric sphygmomanometer (Cor Medical Corporation, New 
York): the Cor 7000 measures mean arterial pressure (MAP; mmHg); systolic blood 
pressure (SBP; mmHg); diastolic blood pressure (DBP; mmHg) and pulse rate (P; 
beat/min) continuously in the brachial artery. 
NCCOM3-R7 impedance cardiograph (BoMed Medical Manufacturing Ltd., 
Irvine, California). The NCCOM3-R7 measures and displays total of 12 
cardiodynamic parameters: Cardiac Output Index (CI; l/minAn?); Heart Rate (HR; 
b/min); Stroke Volume (SV; ml) / Stroke Index (SI; ml/m^); Peak Flow / Peak Flow 
Index; Ejection Fraction (EF; %); End-diastolic Volume / End-diastolic Index (EDI; 
ml/m2); Index of Contractility (l/sec); Thoracic Fluid Index (TFI; Ohm); Acceleration 
Index (ACI; 1/sec/sec); Ventricular Ejection Time (VET); Ejection Ratio (Preload 
Index) and Systolic Time Ratio (STR; %). 
Electrodes (CONMED), Consolidated Medical Equipment, Inc. 310 Broad 
Street, Utica, New York 13501. U. S. A. 
Computer/Printer Output. 
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Grip dynamometer (Takei Kiki Kogyo, Japan). 
Comtech 486: IBM compatible 486DX personal computer with external 
Bernoulli 150 megabyte cartridge drive. 
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2. Studies: 
2.1 Validation of Cor 7000 sphygmomanometer 
2.1.1 Patients 
• 
Twenty patients were selected from in-patients in the antenatal ward of the 
Prince of Wales Hospital, the teaching hospital of the Chinese University of Hong 
Kong from February, 1994, to April, 1994. Their median gestational age was 250 
days (range 182 - 285). Five of these patients had a clinical diagnosis of severe, 
proteinuric PIH and six had mild to moderate non-proteinuric PIH. The remainder 
were normotensive with non-medical conditions, such as placenta praevia. 
2.1.2 Methods 
The cuff of the Cor 7000 was placed over the left brachial artery and that ofa 
Dinamap over the right brachial artery. The Cor cuff was inflated, partially deflated 
and calibrated at a pressure between 10 and 20 mmHg. The Dinamap was then 
activated and simultaneous diastolic, systolic and mean arterial pressure (MAP), and 
pulse rate were recorded from both sphygmomanometers; the Cor values being 
recorded at the time the Dinamap completed its measurement cycle. Three to four 
readings were taken from both machines at five-minute intervals until the 
measurements stabilised. Isometric handgrip exercise was then performed by using a 
grip dynamometer at 30% of maximum for a period of two minutes, and using the left 
hand (Cor arm). Blood pressure recordings were then performed by using both 
machines at one minute and two minutes after cessation of exercise. 
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2.1.3 Statistics 
Analysis of variance with repeated measures (SPSS 6.1 for Windows) was 
performed with two within-subject variables of sphygmomanometer type and time, 
one between-subjects variable PIH category (normotensive, non-proteinuric PIH and 
proteinuric PIH) and blood pressure (diastolic, mean and systolic) as dependent 
variable. 
The patterns of MAP response to isometric exercise were examined 
graphically for each of the 3-patient categories. 
« 
• 
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2.1.4 Results 
Figures 1.1 (la) and ( lb) show the comparison ofDinamap and Cor readings 
of diastolic, mean and systolic brachial artery pressures before and after isometric 
exercise respectively. The readings were highly correlated (r > 0.8)，with only 
slightly greater dispersion after isometric exercise. 
Analysis of variance with repeated measures showed a significant difference 
between the paired readings, by using the different sphygmomanometers (p = 0.009) 
»• 
due to a mean difference of 4mmHg; the Cor 7000 tending to give higher readings 
than that of the Dinamap. Variation due to time was the largest factor (p < 0.0001). 
No significant variation due to interaction between type of sphygmomanometer and 
time of reading in relation to isometric exercise (p = 0.226) or between these two 
variables and PIH category (p = 0.055). There was significant interaction between 
PIH category and time of measurement (p =0.048). These results are summarized in 
table 1. 
There was no significant difference in maternal age, height, weight and 
gestational age between the normotensive and PIH groups. 
Figures 1.2 (2a), (2b) and (2c) show the changes in individual MAP reading 
for each patient in normotensive, non-proteinuric and proteinuric PIH patients 
respectively. The differences in response to exercise between normotensive and PIH 
patients can be clearly seen; Normotensive women demonstrated a sharp increase in 
MAP within 1 minute of stopping isometric exercise which stabilised or dropped (3 
out of 9) by 2 minutes. Patients with proteinuric PIH tended to have a slower 
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response to isometric exercise, 4 out of 5 patients demonstrating a continuing rise in 
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Table 1: Results of repeated measures analysis of variance in blood pressure 
measurement before and after isometric exercise. 
〜 ^ • ^ ^ … 、 ^ 、 … … … 、 、 … ^ • . … … . . … 、 … . … • • • . 、 … • • … … . … . … … … … … … … … … , … ^ ”nnnm， 
Effect HotelIing's t F Significance o f F Effect Size 
PIH 1.35 3.16 0.017 0.4 
PIH by sphygmomanometer 0.39 0.9 0.506 0.16 
Sphygmomanometer 1.11 5.53 0.009 0.52 
PIH by time 2.45 2.25 0.048 0.55 
Time 8.62 17.24 0.000 0.9 
Sphygmomanometer by tinie 0.81 1.61 0.226 0.45 
PIH by sphygmomanometer 0.42 1.06 0.398 0.12 
by time 
认^、从认、认认认认**^认*»、、、认*»、*•••»、、、^、、、、、认*>«••、•》«•*•、、S«.、》1、、》«、、*•、、《•、、《•、•.》.、、、•、、、、、、、、、S*.S«.«.*.«.«.«.*.«.«.».».«.«.».«.*.«>V.<.«wV*>«.<».*.».«kV».«.«.>.K».^*.»j«.«.«.».«->.>-i-«.>->-«-».«.气《^、《.气气>^塵.、《^气_1气》_气气气《^气<^-^«^-^«|_久气气气气气气气《^气《^^^^ *• • • - • •叙• •牵•皿 _• • • * • •叙• • _• • • • • • • •象急• • • • ••• 
< 
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2.2 Platelet ANG IT receptor status and svstemic vascular resistance 
2.2.1 Control subjects 
Fifteen healthy, non-pregnant female volunteers with regular menstrual cycles 
were studied: their ages are summarized in Table 2.1. None of the them had taken 
contraceptives within the last year, and none were taking any medication at the time 
of testing. 
2.2.2 Patients 
A randomized controlled trial of prevention of PIH in high risk patients, by 
low-dose aspirin or calcium supplementation, is already under way in the Department 
of Obstetrics & Gynaecology, The Chinese University of Hong Kong. 500 
primigravid Chinese women will be recruited from the antenatal clinic, on the basis of 
raised MAP-2. These patients are selected because of an initial MAP greater than 85 
mmHg (sitting, mercury column sphygmomanometer), at their antenatal clinic visit 
between 18 - 24 weeks of gestation. All patients were normotensive (Blood pressure 
< 140/90 mmHg) at booking in the first trimester, and at the early second trimester 
visit. They are further screened in a research setting using a Dinamap automatic 
oscillometric sphygmomanometer in the left lateral position (Rogers et al 1994， 
1995). Patients fulfilling the recruitment criteria of a resting MAP > 60 mmHg were 
I 
I 
then randomized into three groups: control, low dose aspirin or calcium 
； supplementation. 
I j 
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63 women were recruited this trial from January, 1994 to February, 1995. 
Their ages and gestational ages were summarized in Table 2.1. None ofthem had a 
prior history of cardiovascular or respiratory diseases. Screening examination, 
including physical examination, full blood count, blood and urine biochemistry were 
tested and were normal. All of them were non-smokers. None of these women gave 
a history of essential hypertension, pulmonary or renal disease, diabetes or recent 
usage of drugs known to influence platelet behavior. They were all subjected to 
ultrasonic examination for confirmation of gestational age and exclusion ofcongenital 
malformations. Prior to enrollment in this study, the nature, purpose and potential 
risks of the study were explained to them and written consent was obtained from 
each subject in accordance with the recommendation of the revised Declaration of 
Helsinki (Hong Kong, 1989). The study was approved by the Ethics Committee of 
the Faculty ofMedicine of the Chinese University ofHong Kong. 
Subjects were investigated at 20-24 weeks and 30-32 weeks, and were 
followed up until after delivery. Tests were repeated in ten ofthe subjects six weeks 
postnatally. 
The clinical outcome of the women was noted. Their developing PIH were 
identified according to the criteria of the Committee on Terminology ofthe American 
College of Obstetricians and Gynecologists. 
Chapter 2 General Methodology 60 
\ 
2.2.3 Platelet preparation and platelet angiotensin II binding site assay 
Platelet ANG I I binding was carried out as described by Baker et al (1990). 
Venous blood (20ml) was obtained from these same patients: all blood 
samples were obtained through an indwelling canula placed in the contralateral arm 
to the sphygmomanometer cuff whilst resting in the sitting position. Subjects were 
not fasted during blood taking. 
All chemicals were obtained from Sigma Chemical Co. and [^^^I]-Tyr^-
Angiotensin I I (human) (10 ^iCi, 2200 Ci/mmol), was obtained from Amersham, UK. 
ANG I I was stored in Tris-buffered saline (Tris-HCimaCL^SA, pH 7.35). Tris-HCl 
buffered Saline (0.6 mmol/L, Tris, 0.5g BSA (w/v), 100ml NaCl 154 mmol/L, pH 
7.35) at a concentration of 0.3 nmol/L. Modified medium 199 was supplemented to 
give a solution containing: 1 liter Medium 199 including 0.32 mmoL^ MgSO4, 0.74 
mmol/L CaCl2, 11.1 mmol/L glucose, 5 mmoL^ ethylenediaminetetra-acetate 
(EDTA), 5.0g bovine serum albumin (BSA) (w/v); pH 7.4. 
Blood was collected into 10 mL standard tubes, sigmacoated beforehand, 
containing 3.13% (w/v) trisodium citrate (1.0 mL) and 25 mM acetylsalicylic acid 
(0.4 mL). 25 mL of blood was needed per assay and was taken using a 19 gauge 
needle. The whole blood was centrifuged at 160 g for 20 minutes at 4®C to produce 
Platelet-Rich Plasma (PRP). The pH of PRP was adjusted to pH 6.4 with 0.1 
mmol/L citric acid and 1 unit/mL apyrase (approximately 1 drop per mL ofPRP) was 
added. The platelets were pelleted by centrifugation (400g for 20 minutes at 4^C) 
and resuspended in modified medium 199. The platelet concentration in a small 
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portion of the suspension was measured in a Coulter JT haematology analyzer and 
the volume of the medium was adjusted to give a platelet concentration of 10^  
cells/^il. 
Platelets in medium 199 were incubated with ^I-Angiotensin I I (300 
pmol/L), with and without an excess of unlabelled ANG I I for 90 minutes at 26¾. 
The bound form was separated from free form by layering a portion ofthe incubation 
medium over 0.2 mL of a mixture of phthalate esters and centrifugation at 13,000g 
for 30 seconds in a Beckman centrifuge. The mixture of phthalate esters was 
prepared by mixing dibutylphthalate/bis 3,5,5,-trimethylhexyl ester in the ratio 8:1 
(specific gravity 1.03). These tubes were frozen by immersing in liquid nitrogen, and 
cut into two portions just below the oil-medium surface with a guillotine; the upper 
portion being the free form and the lower portion being the bound form. The 
radioactivity of the bound and free ANG I I was counted using a COBRA A5005 
auto-mini-gamma counter. Platelet ANG I I binding was expressed as fmol of ANG 
II /109 cells. 
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2.2.3.1 Statistical analysis 
As platelet ANG I I binding was not normally distributed in pregnancy; non-
parametric statistical methods were used throughout the analysis. 
Inter-group comparisons of platelet ANG I I binding and haemodynamic 
indices were performed by the Mann-Whitney U-test for two categories and Kruskal-
« 
Wallis one-way analysis of variance when more than two categories were compared. 
Inter-group differences in platelet ANG I I binding and haemodynamic 
measurements between the second and third trimesters, and between pregnant and 
postpartum women were tested with the Wilcoxon matched-pairs signed-ranks test. 
Friedman two-way analysis of variance was performed when more than two sets of 
measurements in the same patients were compared. 
Correlations between ANG II binding concentrations and haemodynamic 
indices associated with position change or isometric handgrip exercise were assessed 
by Spearman correlation. 
1 
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2.2.3.2. Results 
Table 2.1. Details of patients. The study involved 15 non-pregnant women and 63 
normotensive women during or after their first pregnancy. Values for age and 
gestational age are mean ± SEM 
\~*»^ W»\S^ <>*»W»t><>WiwM>*AA«»*»«>«»*»«W、、<>M»«»»»S«>«»、《»S«»«>>M»、、M«<»\、《>«»«»*A、M>、、M»、、、、、、、M»、、《»*>、《A^、》»«><K«A«k<A、、、《A«L、^ A、》AV»»*A»_iL«u«>*»»A»>«^ »>‘*Aii«_*_«_«^ i‘《Ai«^ mmm«’、、、》^”,、、,《_«^ «_,、,,,,、’《^、《^ «^ f^ 1_f^ ^^ i^^ p^ f^ »^ ^^ ^^ _^ «^ _^»^ «^^ p^ «^^ _^ ^^ -^ «^ «^ «^ \^^ «^ _^ _^ y^^ «^^ «^ »^^ -^ _^^ _^^ »^ _^ <^ ^ 
Group Number of Age Gestational age 
.yy!.9H!.M. (years) (weeks) 
Non-pregnant 15 26.0 ± 0 . 9 
( 1 7 - 3 5 ) 
Pregnant 63 27.46 ±0.57 22.2土0.82 
2nd trimester (19 - 37) (20 - 24) 
Pregnant 29 28.72土0.88 32.6士3.09 
3rd trimester (19 - 37) (28 - 36) 
Postnatal 10 30.6 ±0 .99 8士3.92 
(24 - 35) (5 - 10) 
WAS\V•^ K*>*AW»〜M^ M^ »^〜《»K,•S«>^ >^ »V»^ *»«»«»«»^ >*^ «^ *»<*•«»^ 、\«•«»^ »«»\«»S«•~«^ «»«•»•^ •^•»•«uM•\•.«•«>^ «^^ 、K^ «^»^ \^>>^ ^^ Ai»••S«w«^ «^ ^^ «^ «^ M»••«>«»«wV«LK^ ASS«^ ••«>^ >»»^ »^>*»*A^ >«AMw«^ »u^ >^»AA«^ «•、 \^^ A¾•«A^ u»•C^ •»^ «^ M•»^ «•^ A«•<^ A\〜NW¾VAV^ •〜V^ •^ W^ A^^ V^ V^ •^ V^WA^ >AA•^ v¾t^ VV^ UtL^ VV^ L^^ LrL^ nrLT〜<VU^ AruVLWUVW^ >^AJ^ f 
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Table 2.2: Results ofPlatelet ANG I I binding before and after delivery. Comparison 
ofplatelet ANG I I binding between non-pregnant women with second, third trimester 
and postnatal women 
W»MbMbWAW^W>«AW»、WA*J»XW、WA、《A、*A*A^^^〜《j«_i«_immi«^mi〜〜i”.iii. ” ” ^,,.^>.^..._...^._^^._._^^^^^^._^^^^^._^^^.^^^^.^^^^^^^^^^^ . • 
Group Number of Platelet ANG II Mann- p 
women binding Whitney U** 
(n) (伸：9!作99.9_?![!斧) 
Non-pregnant 15 3.12 
women (0* - 13.39) 
Pregnant in 63 3.53 429 0.58 
second trimester (0=^  - 28.93) 
Pregnant in third 29 5.43 162 0.17 
trimester (0=^  - 15.84) 
Postnatal 10 5.49 53 0.22 
(1.19 - 33.88) 
*^*^ *^»l^*A»\从<^\^A^S*»«»S^A\«^«»^^^ «^»«^«^ »^•>»S^••^、^»«^ »^*^S«»\SW<^»^«•>»»U^ 、^••••^»•,K^•«^«•¾»•••«>«^«^«»«^K«l»«^ »^«»、K•,K^»••V»^••S^»«^««»^K»^^^«»«•«»«»^ »^«^«»«>«»«»^»V«^K»>认《»^>^>l^\>^«l»^>»»^>、《-<»•<•、*•t•»>¾•«>^ •^¾•»•«•^ >^•>•«•»•>•»•^•mJ•^•^•，ll^ 年^气，气气^A〜气^ \^«^^^•^^^^^^^气^ 气^《^^^_•yy|_•y^J^J^r^ 气^^^^^^|^1^气^^^«^^^^^J^ •^^J•^«^^^_气^^^ J^^^^^^^^^^^^^^^^^^^^•鱼.••••  • _-•_• _ • • 
* Platelet ANG I I binding < 0.5 fmol/10^ cells were coded as zero. 
** Mann-Whitney U calculated between non-pregnant controls and pregnant or 
postnatal values. 
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Table 2.3: Results ofPlatelet ANG I I binding before and after delivery. Comparison 
ofplatelet ANG I I binding between second trimester with the third: second trimester 
with postnatal: and third trimester with postnatal in the same woman 
*>*"*»^ *^W*»*>、*»、\、、S*>W、、*»*»、*»、*»、、、、、、、*»*»*^*»、、*^«>«»、、«~»>*~、、《»««、、、、》>S、、《~、、、、«»、、、、》»、《«、》»、《«、、、、《»、,.S、、、、、、、、、、、、、、-‘<L、《u、«»t>«L、、、‘K、«>«w^‘i、》_‘、i«_ii«Li«>4>«^ »^««、《_«_、S«>«»、《»、《<、、、《k«>«»«L\S«^N1_*^ A^«^"V\_VVWVW«^t\"V%AWL"WVWVV1WL«uWV\1"LfVirL"VVLVVUVVW<AA"VLWVVVLfVVWWLArLrutn 
Group Number of Platelet ANG I I Wilcoxon Matched- p 
women binding Pairs Signed-Ranks 
(n) ( ^ ^ ^ . ? L ? ? M Test: Z** 
Pregnant in second 63 3.53 2nd versus 3rd 
trimester (0* - 28.93) trimester 0.80 
-0.27 
Pregnant in third 29 5.43 3rd trimester versus 
trimester (0* - 15.84) postnatal 0.24 
-1.17 
Postnatal 10 5.49 2nd trimester versus 
(1.19 - 33.88) postnatal 0.44 
-0.76 
<»^ «>W»W>«»«»M»^ M^L_«»VS«~、,.》»».«~、》A,.«<»,».M.»A«»«^ «»«>S*.«.»>*.、M.»>»,»._,«>«.«»_,«»»,«^ ».M.,.«‘《«».”.》.«.*,«._.»,«.i>«,«»«»»,».«.,AS>~V...«,«»«»_.«««.»»«»«»、《.«...».Mi»«»»A 
* platelet ANG IT binding < 0.5 fmol/10^ cells were coded as zero. 
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Table 2.1 shows the characteristics of the women at the time of study. The 
age ofthe non-pregnant women were comparable with the pregnant women. 
Figures 3.1, 3.2, 3.3 and 3.4 show the scatterplots ofplatelet ANG I I binding 
against maternal age, height, weight and weight for height respectively. The highest 
correlation was with weight for height (r=0.333, p<0.05). 
Table 2.2 shows the platelet ANG I I binding in non-pregnant, second 
trimester, third trimester and postnatal subjects. The latter 3 groups were compared 
with the non-pregnant controls using the Mann-Whitney U test. The median value of 
platelet ANG I I binding was 3.12 fmol/10^ cells (Figure.3.5) in the non-pregnant 
group, 3.53 fmol/10^ cells in subjects at the second trimester, and 5.43 fmol/10^ cells 
in subjects at the third trimester. In 10 of the women studied, the median ANG I I 
binding was 5.49 fmol/10^ cells at 8 weeks after delivery. There was no significant 
difference in platelet ANG I I binding in the second or third trimester ofpregnancy, or 
in the post-natal period, when compared with the non-pregnant control group (p = 
0.58, 0.17 and 0.22 respectively). 
Table 2.3 shows the paired comparison of platelet ANG I I binding in the 
pregnant women between 2nd and 3rd trimesters, between the 2nd trimester and 
postnatal, and between the 3rd trimester with postnatal pregnant. There were no 
significant differences observed between these groups. Similarly Friedman two-way 
analysis of variance in the 10 patients tested in second and third trimester of 
pregnancy and 8 weeks postnatally showed no significant differences in platelet ANG 
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Figure 3.5 Platelet angiotensin II binding in controls, pregnant women at 
second and third trimesters and at postnatal (open circle represent data outside 
10th and 90th percentiles). 
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Table 2.4: Comparison of platelet ANG I I binding in three groups of pregnant 
women before fsecond trimester) and after〔third trimester) randomization to receive 
either calcium supplement, low-dose aspirin or act as control cases. Analysis were 
performed bv Kruskal-Wallis one-way analysis of variance 
M A V V W W W V W W S S W ^ W S W « . ^ V W « . ^ W W W ^ ^ « . W S W « . ^ W ^ W 1 , W ^ V ^ ^ ^ 
Calcium Aspirin Control Chi p 
Scjuare 
Second Trimester 
No ofpatients 23 23 17 
Platelet ANG II 5.7 3.74 4.4 1.99 0.369 
binding (1.06-16.9) (0-28.93) (1.53-9.8) 
Third Trimester 
No ofpatients 11 9 9 
Platelet ANG IT 7.38 5.78 3.63 6.10 0.047 




Chapter 2 General Methodology 73 
All pregnant women studied were normotensive in second trimester. Table 
2.4 shows the measurements of platelet ANG I I binding in the three groups of 
patients who according to their randomization into controls or treatment groups 
either receiving calcium supplementation or low-dose aspirin. KruskaI-Wallis one-
way analysis of variance showed that there was no significant difference among the 
three groups prior to treatment (p = 0.369 in second trimester) but treatment 
significantly altered the distribution of platelet ANG I I binding (p = 0.047 in third 
trimester). 
• . 
In pregnant women at the third trimester, Mann-Whitney U tests showed that 
there were no significant differences between the calcium supplement and either the 
low-dose aspirin (p = 0.909) or control (p= 0.063) groups, but a significant 
difference was observed between the low-dose aspirin and control groups (p = 
0.015). The low-dose aspirin group demonstrating higher platelet ANG I I binding 
than the control group. 
There were insufficient cases examined post-natally to determine whether 
these differences persisted after cessation of treatment. 
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2.2.4 Using impedance techniques in combination with continuous 
measurement ofmean arterial pressure to estimate systemic vascular resistance 
2.2.4.1 Measurement of cardiac output by impedance cardiography 
Impedance cardiography was performed shortly after recruitment, before 
commencing aspirin or calcium treatment, by using the NCCOM3-R7 impedance 
cardiograph with simultaneous continuous blood pressure monitoring by the Cor 
7000 monitor. Results were recorded on an IBM compatible, personal computer. 
Investigations were done in the Department of Clinical Pharmacology ofthe Chinese 
University under the supervision ofDr. Brian Tomlinson. 
The technique of impedance cardiography has been described in detail 
(Bernstein DP, 1986a). Transthoracic electrical bioimpedance (TEB) provides a non-
invasive method of estimating aortic blood flow by measuring resistance to an 
alternating electric current of thoracic body tissues. A sinusoidal alternating electric 
current of2.5 mA and 70kHz is applied between current injecting electrode pairs on 
the lateral aspects of the neck and on the mid-axillary line at the level ofxiphisternum 
of the lower chest. Height and weight were entered into the microprocessor. Body 
surface area (BSA) was calculated from these data. Since the alternating electric 
current is of low magnitude and high frequency, it is safe and not perceptible to the 
subject. The voltage is then detected by two inner sensing electrode pairs placed 5 
cm from the corresponding current injecting electrodes and parallel to the current 
path (Figure 4.1). Briefly, in the supine position, 8 surface electrodes are placed at 
precise points on the neck and lower chest, and are 
1 
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Figure 4.1 Electrode positions for measureing thoracic impedance changes. Pairs of 
/ . 
electrodes are placed 5 cm apart at the IeveI of the neck and xiphisternum. I repressents 
current injecting electrode. R, represents sensing electrode for recording transthoracaic 
electrical bioimpedance signal. 
^ : ^ ^ ^ ^ � " = . … I 
^ # ^ ) : f J 
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connected to the non-invasive cardiac output monitor. The waveform of the first 
derivative ofthe impedance signal (dZ/dt, V/OhnVsec) with the automated instrument 
reflects aortic blood flow (stroke volume), and can be used to derive measures ofthe 
ventricular ejection time (VET, B-X interval), basal impedance (Zo) and peak systolic 
rate of change of impedance (dZ/dt[max]). They are calculated using algorithms 
incorporated in a microprocessor (Figure 4.2). In addition, CO and stroke volume 
(SV) are calculated using the Sramek-Bernstein formula (Thomas et al, 1990; Sramek 
1993). CO is the volume ofblood the heart pumps in one minute and is measured in 
liters/minute (L/min). The resting CO is a function ofbody mass and metabolic rate. 
Normal resting CO of a premature 1 kg infant is 0.27 L/min; healthy 3.5 kg full-term 
newborn is 0.87 L/min; 50 kg female adult is 5.0 L/min and an 85 kg male adult 
builder is 8.5 L/min (Sramek BB, et al, 1987). At peak exercise, the CO ofa healthy 
subject can increase fivefold. However, dividing the CO value by body surface area 
(BSA) or by body weight (BW) to produce a Cardiac Index (CI) provides a more 
accurate measure oflevel of pump performance capability than using CO value alone 
when comparing subjects. The measure of CO-by-BSA is less affected by metabolic 
rate than that of CO-by-BW. CO/by/BW should not be used in overweight persons 
whose weight is more than 30 % in excess of the standard weight. Therefore CO-by-
BSA is more frequently used to assess adequacy of perfusion than CO/by/BW. For a 
young adult, the normal value of CI is 2.8 - 4.2 L/min/m^by BSA (2.5 - 4.5 L/min/Kg 
by weight). 
Stroke volume (SV) describes the volumetric delivery of the heart for each 
contraction. The resting value of SV depends on a person's age and body size ofthe 
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4.2. Derivation of systolic tinie intervals from tlie ECG and first derivative impedance 
cardiogram (dZ/dt). B represents aortic valve opening, Z represents peak aortic flow. X， 
represents aortic valve closure. PEP = preecjection period and VET = ventricular ejection 
time. 
202 
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subject. SV value is afFected by heart rate, preload, contractility, afterload and 
ejection fraction. During exercise, SV increases starting from resting heart rate level 
until 120 beats/min level, after which the SV plateaus in healthy adults. For a healthy 
adult during peak exercise, SV can increase by 75 % in comparison to its resting 
value. SV is calculated as by Sramek-Bernstein's formula: 
SV = VEPT X VET X (dZ/dt),^/Zo 
Where SV is measured in mL, 
VEPT stands for volume of electrically participating tissue (intrathoracic); this 
volume (ml) is calculated by the system microprocessor in relation to sex, height and 
weight. 
VET stands for Ventricular Ejection Time in seconds (sec). 
(dzy'dt) max is the rate of change ofimpedance during systole in ohm per second. 
Zo is the basal thoracic impedance in ohms. 
The Sramek-Bernstein equation has been incorporated into BoMED 
NCCOM3-N7 which calculates and displays stroke volume from the values of base 
impedance (Zo), the ventricular ejection time and the maximum magnitude of the 
impedance change (dz/dt)(丨而）and using the heart rate then gives an estimate of 
cardiac output. 
1 
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From the formula listed above, SV has to be normalized either by BSA or by 
Body weight to obtain comparable pump performance values. For a young adult, the 
normal value ofSV by BSA is 50 (40 - 60), and SV by weight is 1.35 (1.08 - 1.62). 
The blood pressure (BP; mmHg), was measured with a cuff 
sphygmomanometer, which was applied to the patients right arm. Diastolic blood 
pressure (DBP; mmHg) and systolic blood pressure (SBP; mmHg) are used for 
analysis. 
The product of SV, and pulse rate (P, beats/min) determine by the value of 
cardiac output (CO, L/min). The reading of the value of mean arterial pressure 
(MAP, mmHg) was taken directly from the Cor 7000, and NOT calculated by the 
sum of the diastolic pressure and one-third of the pulse pressure. These values 
provided us with a measure of peripheral resistance in arbitrary units expressing the 
ratio between MAP & CO in dyn.sec'\cm''. So, total peripheral vascular resistance 
(TPVR, dyn.sec''.ctn"^) is estimated from the following formula: 
TPVR (dyn,sec ^cm ') = MAP (mmHg) X80/C0 (L/min) 
HR is determined directly from the R-R interval of a simultaneously recorded 
electrocardiograph, HR is a compensatory variable connecting SV and CO, since CO 
is calculated according to the following formula: 
CO (m1/min) = stroke volume (ml) x heart rate (beats/min) 
where stroke volume equals velocity integral (cm) times cross-sectional area (cm^) 
• . 
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For a poor ventricular performance (low SV), the pump can increase HR and 
still perfuse the body tissue adequately. However, if the resting HR is close to 120 
beats/min at which SV augmentation stops, the HR becomes the only perfusion 
compensatory mechanism. In the absence of conduction defects, a lower HR, in 
general, indicates better left-ventricular performance. HR decreases with age. 
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2.2.4.2 Validity of transthoracic electrical bioimpedance technique 
The use of the transthoracic electrical bioimpedance technique (TEB) was 
introduced more than twenty years ago. Nevertheless, the validity ofthe technique is 
still a matter of debate. Various studies have been conducted to examine the 
reproducibility of TEB over time as well as comparison of the technique with other 
so-called standard methods of CO measurement. 
Measurement of CO can be either invasive or non-invasive depending on 
pathophysiological conditions of the patients involved or the purpose and scope of 
the study. The former includes Fick's method, dye dilution, thermodilution or 
，. 
radionuclide dilution and the latter electrical impedance cardiography or transthoracic 
electrical bioimpedance, dual-beam Doppler echoaortography and M mode 
echocardiography. All the invasive and non-invasive methods mentioned above 
estimate CO and SV indirectly (Breithaupt et al 1990). The validity of the non-
invasive measurement of CO has been demonstrated by many studies which were 
conducted to correlate noninvasively obtained CO data with whose determined by the 
better recognized invasive techniques. Breithaupt et al (1990) compared four 
noninvasive techniques, electrical impedance cardiography, dual-beam Doppler 
echoaortography, mechano-sphygmography and M mode echocardiography of the 
left ventricle to measure SV in nine healthy volunteers. They found that the electrical 
impedance cardiography had the correlation closest to the principal component using 
principal component analysis with r=0.89. The correlation coefficients, r，for the 
dual-beam Doppler echoaortography, mechanosphygmography and M mode 
1 
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echocardiography of the left ventricle were r=0.87, r=0.84 and r=0.66 respectively. 
They concluded that the first three noninvasive techniques were all of reasonable 
validity for estimation of SV. 
Non-invasive measurements of CO and SV have always been criticised as 
being less accurate and less reliable than those obtained by invasive techniques. 
However, it is noted by many reputable researchers that even the invasive techniques 
have flaws in their design principles and cannot give true values of SV. Hence, it has 
been commonly agreed that a standard method for measurement of CO does not 
really exist. 
A number of studies have compared impedance cardiography (IC) with more 
established techniques in the non-pregnant and pregnant subjects. Milsom et al 
(1983) reported a good correlation (r=0.87) between impedance cardiography and 
the thermodilution technique for the measurement of stroke volume in late 
pregnancy. However, IC was significantly (p<0.01) lower than mean stroke volume 
calculated by the dye dilution (DD) technique. Furthermore, he demonstrated 
intrathoracic fluid volume, thorax configuration, and haematological changes 
influence the determination of SV by IC method. A progressive change takes places 
in these physiological factors from early to late pregnancy with additional changes 
occurring at the time of parturition and postpartum. The reliability of impedance 
cardiography for the longitudinal investigation of SV during pregnancy would 
therefore appear to be limited. The author explained that ability of impedance 
cardiography to determine changes in cardiac stroke volume was not affected by 
changes in body position. It is because measurement of cardiac stroke volume with 
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impedance cardiography allows repeated determination of SV in the same individual, 
without any of the disadvantages associated with invasive techniques. When using 
invasive techniques such as DD it has not been possible to perform more than a 
limited number of measurements in each individual. Masaki et al (1989) reported an 
excellent correlation (r=0.91, p<0.001) between results from impedance cardiography 
and thermodilution in the late pregnancy and concluded that the impedance technique 
was valid in most patients with certain obvious exceptions. 
Easterling & Benedetti (1990) criticised this report pointing out that the 
impedance technique consistently underestimated CO relative to thermodilution and 
this was particularly so in patients with PET. Easterling et al (1989) found a poor 
correlation between impedance and thermodilution techniques (r=0.17) in 10 patients, 
6 of whom had severe PET but the discrepancies between measurements with 
thermodilution and impedance cardiographpy in their normotensive patients were 
much smaller. The impedance technique markedly underestimated the CO in these 
patients as was the case in some cases in Masaki's series (1989). This corresponds to 
the underestimation of CO by the impedance technique in hyperdynamic sepsis 
(Bernstin et al., 1986). 
A further consideration is when measurements should be taken to provide 
baseline values representative of the non-pregnant state. Measurements before the 
pregnancy would be ideal but this is impractical in a study of this nature so post 
partum measurements are more often made. Capeless & Clapp (1991) found that 
stroke volume and end-diastolic volume estimated by M-mode echo cardiography 
remained elevated compared to preconception at 6 and 12 weeks although heart rate 
i 
1 I 1 
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and mean arterial pressure were not different. Systemic vascular resistance was 
therefore still reduced at 12 weeks post partum. 
Robson et al (1987) found that the majority of the fall in cardiac output 
(28%) had occurred by their first measurement at 2 weeks post partum but a further 
progressive fall was seen up to the last measurement at 24 weeks (33%). Indices of 
myocardial contractility had declined by 2 weeks and there was no further change 
thereafter. 
Changes in CO in longitudinal studies throughout pregnancy estimated by 
Doppler ultrasound have not given entirely consistent results. McLennan et al (1987) 
found minute distance estimated at the aortic arch, which is proportional to CO, 
showed a maximum increase of 30% in the left lateral position at 24 weeks. 
However, studies from Robson et al (1989) showed the CO, estimated by Doppler 
and cross-sectional echocardiography, reached a peak at 32 weeks gestation. 
The changes in SV and other cardiovascular indices during pregnancy have 
been demonstrated in a longitudinal study using the IC technique, the results ofwhich 
were described in three reports (Atkins et al 1981 a&b, Davies et al 1986). In this 
longitudinal study, SV and CO rose to a peak by the end of the fist trimester, 
remained constant until the third trimester, and then gradually fell to pre-pregnancy 
levels. This pattern was similar, irrespective ofbody position. This is contrary to the 
accepted pattern and seems unlikely on theoretical grounds. Further analysis of the 
data showed the effect was mainly due to a gradual fall in the dx/dt value from the 
impedance traces, with some contribution from fall in mean impedance and 
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ventricular ejection time (Davies et al., 1986). de Swiet & Talbert (1986) argued that 
the fall in dz/dt during pregnancy is due to various factors. One of the major 
assumptions of the method is a constant ejection flow rate, equal to the initial flow. 
It is most likely that the flow/time profile changes in the course of pregnancy, 
because ejection time is substantially reduced as pregnancy progresses (de Swiet & 
Talbert, 1986). 
Additionally, the use of TEB in pregnancy was also established in a study 
comparing CO in peripartum patients by TEB and TD. It showed strong agreement 
between the two techniques within 土 20% (Masaki & Greensopoon, 1989). 
Moreover, the place of TEB for CO estimation in patients with pacemakers has been 
reviewed (Ovsyshcher, 1993). The authors claimed that a good correlation with an 
'r ' value of 0.7 to 0.9 has been found in most studies comparing the TEB technique 
with other reference methods and that the high reproducibility of TEB is comparable 
or even better than other widely used techniques in pacemaker patients. In addition, 
TEB permits the detection of trends of small changes in CO on a continuous basis. 
In summary, the reproducibility of TEB over time is well documented and 
validated in the literature and most of the studies comparing TEB with other standard 
methods of CO estimation showed promising results. Moreover, TEB can detect 
small changes of CO produced by postural changes, during exercise (such as the 
isometric hand-grip test, which produces a vasoconstrictor effect, mediated by the 
sympathetic system) and stressor procedures. With its non-invasive, easy to perform 
and continuous monitoring properties, in intensive care settings as well as out-
patients clinics for cardiac assessment is TEB may be useful for initial assessment 
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before resorting to more invasive monitoring. However, extensive use of TEB in 
place of other methods of haemodynamic monitoring warrants more comprehensive 
and meticulous studies in different clinical situations. 
• 
1 
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2.2.4.3 Measurement of mean arterial pressure. 
The Cor 7000 produces a continuous reading of MAP by using a standard 
cufF placed over the brachial artery and maintained at an inflation pressure of 10-20 
mmHg. Physiologic waveforms are transmitted to a transducer via non-compliant 
tubing, where the signal is amplified. The electro-pnematic system is designed to 
minimise signal to noise ratio to enable production of a clean, raw waveform signal. 
The normal output of the machine is analog but some minor electrical modifications 
have enabled us to obtain a digital output which can be downloaded onto a computer. 
2.2.4.3.1 Experimental technique. 
Before commencing the study on pregnant patients, maximum handgrip was 
determined. 
In a recent study (Anderson, 1993), maximum handgrip was firstly 
determined with a grip dynamometer (0 - 100 kg W; Takei Kiki Kogyo, Japan). This 
method proved to be unsuitable for maintaining the grip, as, after the initial pressure, 
the needle remained at its maximum level and had to be manually reset to zero. It 
was therefore possible to slacken the grip without affecting the reading. In my study, 
maximum handgrip was determined by using the grip dynamometer whereas a rubber 
bulb, which was attached to a portable sphygmomanometer in place of the cufF, was 
used for the isometric handgrip exercise test at one-third of the maximum handgrip. 
This system was more sensitive to fluctuations in grip. 
f 
1 
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The reading of grip dynamometer is in Kg which is needed to be converted 
into "mmHg". The formula used was to calculate the pressure required for the 
handgrip exercise test was: 
Han(Ignp(niinHg) = Handgrip (kg) xl3 x30 % 
This was derived by testing the 15 non-pregnant volunteers; measuring their 
maximum grip in Kg by the grip dynamometer and also in mmHg by using the 
sphygmomanometer. None of these women were strong enough to push the needle to 
the maximum on the portable sphygmomanometer. The volunteers repeated the 
exercise three times and the mean of the three readings for each instrument was 
taken. The following calculation was then performed for all 15 subjects: 
• • 
# 
mean value in mniHs = Con version factor (13) 
mean value in Kg 
Non-invasive haemodynamic nionitorins: 
Fifty nine Chinese pregnant women were recruited for the part of this study. 
Each patient was weighed and had their height measured. The height and weight of 
the subject were entered into the microprocessor, which interpreted the electrical 
. ‘ • 
impedance signal with these data, and provided a reading of the CI, SI and HR with 
_ each cardiac cycle. Self-adhesive pregelled silver/silver chloride electrodes (Cor-Med 
Corporation, USA) were applied to the neck and lower chest as shown in Figure 2 
and the cables were connected between the subject and the BoMed NCCOM-R7 
I 
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impedance cardiograph. A cuff was placed on the right arm and connected to an 
automatic sphygmomanometer (Cor 7000). The different haemodynamic parameters 
were recorded on a Comtech 486DX: IBM personal computer with external 
Bernoulli 150 megabyte cartridge drive computer connected to the thoracic electrical 
bioimpedance (TEB) -BoMed NCCOM-R7 by an RS-232 connector. The BoMed 
impedance cardiograph analyses the changes in the impedance signal during each 
cardiac cycle and indicates continuously in real time the following digitally displayed 
variables which can be indexed by body surface are (BSA): The NCCOM3-R7 
measures and displays total of 11 cardiodynamic parameters: Cardiac Output Index 
(CI; l/min/m^); Stroke Index (SI; m\/m\ End-diastolic Index (EDI; m lW) ; Peak 
Flow Index (PFI); Ejection Fraction (EF; %); Heart Rate (HR; b/min); Thoracic Fluid 
Index (TFI; Ohm); Index of Contractility (IC); Ejection Ratio (ER); Systolic Time 
Ratio (STR; %); and Acceleration Index (ACI; 1/sec/sec);) in slow mode (SM) in fast 
mode (FM) CI; SI; EDI; PR1; EF; and HR only. Slow mode represents averaged 
values of the haemodynamic parameters after every 16 beats detected and analysed 
by the TEB while FM represents calculation and display of relevant parameters for 
each heart beat which can be analysed. 
Personal parameters pertaining to each subject including a specific subject 
code, body weight and body height were entered into the machine to calculate BSA 
which was then used to estimate the stroke volume index using the Sramek-Bernstin 
formula . Thoracic length (L) was calculated by 17% of height adjusted for weight 
according to Bernstein's correction nomogram incorporated in the machine 
(Bernstein, 1986). After input of the subject's particulars, the haemodynamic 
1 
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variables estimated by the TEB were saved on the Bernoulli 150 megabyte cartridge 
drive computer. 
Every attempt was made to keep the environment as quiet as possible afid the 
subjects were asked not to speak once the monitoring session had begun. The patient 
rested for 10 minutes in the left lateral recumbent position before measurements were 
made. Firstly, a ‘roll over’ test was performed. As soon as the patient turned from 
the left lateral to supine position, immediate changes were noted: The pulse rate, 
systolic, diastolic and mean arterial blood pressures were measured before and 
immediately after the "roll over”，by the Cor 7000. The patient then rested in the 
supine position for a further 5 minutes, and the readings of these parameters were 
recorded with 1-minute intervals. The patient was then asked to sit in a semi-prone 
position and a similar set of recordings was made. CI, SI, EDI, PFI, EF, HR, TFI. 
ER, IC, STR, ACI were continuously recorded by NCCOM3-R7 in each of three 
position and during the changing of the position, in order to assess the second-second 
variation and the reproducibility of the method. 
After a flirther period of 10 minutes rest in the sitting position, isometric 
handgrip exercise was performed for 2 minutes with left hand at one-third of the 
patient's predetermined maximal voluntary contraction force. 
CI, ST, EDI, PFI, EF, HR, TFI. ER, IC, STR, ACI were continuously 
measured during the two minutes. The systolic and diastolic blood pressure, mean 
• 
arterial pressure and pulse were also recorded at one and two minutes. Thfe same 
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constant baseline diastolic blood pressure had been established. Blood pressure 
measurements were performed in the passive (right) arm by using a standard cuff 
attached to the Cor 7000, positioned at the level ofthe heart. 
Haemodynamic measurements were measurement were measured at each monitoring 
session using the following protocol: 
a) after resting for 10 minutes in the left lateral position. 
b) starting in the left lateral position for 1 minute (Fast Mode). 
c) turning from left lateral to supine position in 3 to 6 seconds.( Fast Mode). 
d) resting supine position for 5 minutes taken each minute (Fast Mode). 
e) after sitting for 10 minutes, starting to take every minute for 2 minute (Slow 
Mode), and continuous to take 1 minute (Fast Mode). 
f) taken every minute for 2 minutes isometric exercise (Slow Mode). 
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2.2.4.3.2 Statistical analysis 
Median and range are given in the text, figures, and tables. Differences within 
groups were tested by Wilcoxon's matched-pairs signed-rank. Differences between 
groups were tested by the Mann-Whitney U test. P < 0.05 was considered 
significant. 
2.2.4.4 Results. 
The 63 primigravidae Chinese women who had been studied for platelet ANG 
I I and were examined by combined impedance cardiography (IC) during the second 
trimester of pregnancy but only 59 of them were folly recorded; the records of the IC 
of four were missing. The median age of this group was 28 (range 19 -37 years); 
median weight was 58.8 kg (range 45.4 - 85.8 kg); and median height was 156cm 
(range 147.5 - 167.5cm). Studies were repeated in 10 women, of 8 weeks after 
delivery. 
1 
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2.2.4.5 Data analysis 
Table 3.1. Details of patients studied in the second trimester and postnatal period. 
Values are expressed as median (range). 
2nd trimester Postnatal Period 
Number of women 59 10 
Age (years) 28 (19-37) 30.5 (24-35) 
Gestation (weeks) 22.2 (20 - 24) Term + 8 (5-10) 
BSA(cm2) 155 (136-163) 160 (141-171) 
Height (cm) 156 (147.5-167.5) 160 (148-167.5) 
Weight (kg) 58.8 (45.4-85.8) 60.7 (50-69) 
Handgrip (mmHg) 81.9 (35-117) 83.8 (62.4-117) 
Platelet ANG TI binding 3.57 (0-28.9) 5.5 (1.2-33.9) 
1 
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Table 3.2: Haemodynamic alterations in response to position change and isometric 
handgrip exercise in the second trimester pregnancy in 59 women. 
*''^^'^^'^'^^^**•^'^•^^*^*^^ 
Fast Mo(Ie Fast Mode Fast Mode Slow Mode Fast Mode Slow Mode Slow Mode 
WkWA«A»w«AWWA«AWAWA~><w«~«Aww、"i^^??)v..~wwjA~j_»A~_、《^、J^^ji}«Ajj^、《^OL«^»^、cLcL»^«^«jjj^iffjjjX^»^»^iii..ii“iii““Ki..y.) " - . . " - . ^ " . ( f i P _ ^ i i n v n n r t i A v i n l _ i Y y i f 3 ^ n ^ V L V u v i j l _ _ u n r t P v w i ^ S ! ? ? ) - , , ^ , - ^ ^ 
Left Lateral Lcft Lateral Supuie Sitting Sittuig Haiidgrip Recovery 
(1 niin) to Supine exercise 
(5niin) (2m|n) (lnrin) (2r^) (5jr^) 
DBP 50 50 49 58 60 60 63 
(niJiiIIg) (35-120) (30-63) (24-86) (23-82) (25-82) (19-81) (23-86) 
MAP 70 70 61 77 78 75 84 
(iiuiiHg) (48-140) (40-114) (36-117) (36-128) (34-130) (36-136) (37-129) 
Cardiac Index 5.9 5.6 6.2 6.4 6.2 5.6 6.3 
CL/iriiii/ni^ ) (2.1-8.6) (0.9-9.4) (2.3-7.7) (2.8-21.1) (2.6-13.3) (2.5-9.2) (1.9-9.2) 
Cardiac Output 9.3 8.6 9.6 10.1 9.7 9.1 9.9 
(l/nuii) (3.2-13.7) (1.5-16.7) (3.8-13.0) (5.0-35.9) (4.6-18.9) (3.7-14.2) (3.2-13.9) 
Stroke Iiulex 89.6 91.5 89.4 79.7 78.5 74.6 79.9 
(ml/m2) (31.4-158) (42.3-159) (29.1-196) (33.8-186) (32.3-167) (29-171) (28.7-201) 
« 
Stroke Volimie 139.8 139.2 138.2 126.7 122.8 118.4 124.7 
(ml) (55.6-269) (55.6-270) (51.5-329) (59,8-316) (47.8-256) (51.3-291) (50.8-342)) 
IIeaii Rntc 85.5 84.4 84.9 88 87.8 90.3 87.7 
(bcats/nrin) (64-104) (55-102) (64-103) (71-108) (73-106) (71-116) (68-109) 
TPVRI 486 510 406 437 460 464 492 
(djiie.s'.cm^.m-) (192-1490) (161-2035) (175-1120) (112-1039) (188-965) (182-861) (210-1276) 
TPVR 1007 974 846 938 995 1000 1014 
(dvne.s-i.cni-s) (600-3443) (478-4800) (440-2817) (322-2626) (478-2537) (422-2220) (529-3537) 
<W^ fl>^ «>«X、、、《>*A、、*A».%«<S*A.. •.•.•.*•”.•••• •>••• KK*.KK «•〜•.《••••••. *•*•”.•.••、\ •.•. *.*.^ *.*.^ *. •.•. *•*• M . •• •. ». *.*1 «•«• «••• »••.、•• •. •. .••>«»•>、»,n^ K».t.^ «.K«.«.^ %«.^ «.ti,S<^  »_*•••• « . ..«. •••» ••«* ••«*••*••••• ••*••••*•••*•—•***•••**•*•.•‘•‘‘‘ •^i* i_*aa__a^ an>*aaa*^ a>,>^ *__,^ ,a|^ |^ ,*_>y>^ >y^ ^^ 7^,^ .^>^ n-^ ^^ j^ _p^ _^^ j>yi_^ ip^ >^ -^ ->^ >^ >^ _^ j^^  
Chapter 2 General Methodology 95 
We observed significant decreases in MAP but not in diastolic blood pressure 
following change in position from left lateral to supine position (p =0.007). This is 
contrary to expectations of an increase and is explained by the positioning of the 
sphygmomanometer cuff on the left (lower) arm rather than the more usual upper 
arm. Despite this we noted that increases in both diastolic and mean arterial pressure 
were observed in 17 out of the 59 cases. MAP did not rise significantly during 
isometric handgrip exercise but did so during the recovery phase (p=0.017). 
Diastolic pressure rose significantly during isometric exercise (p=0.013) but was not 
significantly different after 5 minutes recovery time (p=0.06). 
Cardiac Index did not alter significantly during or after position change from 
left lateral to supine or during or after isometric exercise. However, correlation 
coefficients relating cardiac output (CO) with total peripheral vascular resistance 
(TPVR) have significantly (p < 0.001) in each postures and handgrip exercise, and 
with stroke volume (SV) have significantly (p<0.001 for sitting position and recovery 
of handgrip exercise; p=0.006 for isometric exercise). Figure 4.3; 4.4; 4.5; 4.6; 4.7; 
4.8; 4.9 and figure 4.10; 4.11; 4.12 were shown the scatterplots ofCO against TPVR 
and CO against plotted for SV. 
Heart rate fell significantly during change of position (p=0.012) but the 
difference after 5 minutes in the supine position did not reach statistical significance 
(p=0.094). Heart rate rose significantly during isometric exercise (p<0.0001) but the 
difference was not significant after 5 minutes (p=0.087). 
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Table 3.3: Correlation coefficients between Cardiac Output and Total Peripheral 
Vascular Resistance of 59 pregnant women 
*^^ **•*»、^^ W^*^ "^ »*»*»~*»*»W*>*>*»~*»*>、、、*»*»*«*>«»*»*>"、、、M>*>、*i»«»、、《>^ «»«>«.、、、》A«»‘、、、《~、、‘《~‘、、》~«~«~、、《~i«_、《~»~«L»~ii«~«~i«^ m«~«~ii«~i«Aii«~*^ «»、i*>«^、《»、《»«»«>、、《»«»_,«««»«_«»«b、《A«>M>«>、、《>«^ »>、《>V^、VV、、VVVVWVLWVVWL->ArL»AVyvVWVVVVV\1fVVVVVVVWVVVuWUVWuWWUWlVUV»Ar 
cardiac output Correlation coefficient (r) Significance of F 
(L/min) 
Rest in lcft lateral for 10 min 
Lcft Lateral 0.7989 P<0.001 
Lateral to Siipinc 0.7656 P<0.001 
Supine 0.7926 P<0.001 
Sitting 0.579 P<0.001 
Fast Moclc (TFm) 
e . “ . 0.7245 P<0.001 Sitting 
SlowMo(lc (Sni) 
Handgrip cxcrcisc 0.7328 P<0.001 
Rccovcry 0.7711 P<0.001 
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Table 3.4: Correlation coefficients between Cardiac Output and Stroke Volume of 
59 pregnant women 
S » W > * > ^ * > M > M » ^ * » * i * » » » K W < N « » l ^ « » < > « » » » S « > « » « » » » » > « > « « « » i » i » « » * » « » » > « » * » « » _ . ~ « ^ « » « , « » « » t > « - « » « » « » » » « » » > « > » . « » � � _ » ‘ � _ * - » _ l « . « . « _ « _ « _ » . i < _ « ^ * _ f c » _ « . m « ^ » _ i i « _ « _ « _ i i * _ i i m « _ « . « . i _ . i i i i i m » . i i * . i » . i i » . » n « . i i « . « » ^ m » . - « • « , « > « - « , « ^ . « - i * > * , * , - , * , > , * • • • • • • « _ « < • • • ^ i ^ * _ * < ^ , ^ , * i ^ r < * i , f l , * L V V i r i A n r r L r L l * V * V V L W V W V V W W V W W V V V W W V V W 
Posture Correlation coefficient (r) Significance of F 
Rest in left lateral for 10 min 
Left Lateral 0.0975 NS 
Lateral to Supine 0.0469 NS 
Supine 0.0188 NS 
Sitting 0.72276 P<0.001 
Fast Modc (Fm) 
〜 . 0.0991 NS Sitting 
SlowMo(lc (Sm) 
Handgrip cxcrcisc 0.3519 P=0.006 
Rccovcry 0.5387 P<0.001 
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Stroke index was unaffected by change of position but fell significantly during 
isometric exercise (p<0.0001). Again the difference did not persist after 5 minutes 
recovery. 
Total systemic vascular resistance did not alter significantly during change of 
position but after 5 minutes the observed decrease was statistically significant 
(p=0.001). There was a small increase in peripheral vascular resistance during 
isometric exercise but this did not reach statistical significance (p=0.34). Systemic 
vascular resistance continued to rise after isometric exercise; the difference reaching 
statistical significance after 2 minutes (p=0.015) and persisting after 5 minutes 
(p=0.016). 
• 
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Table 3.5: Haemodvnamic alterations in response to position change and isometric 
handgrip exercise in 10 postnatal women. 
Fast Mode Fast Mode Fast Mode Slow Mode Fast Mode Slow Mode Slow Mode 
(Fni) (Fni) nFm) (Sm) (Fm) (Sm) (Sm) 
WA«AWW*wvywwj...wjjA«A、、wj_»jA«j^^^W.-.-»_<f..i〜.-^i..“.ii...“..、：.i‘./. .、 /. /• , ”..、-’’...《’---，n-,n.，.n,n.”.，_^m;,mv(^^”’.，”n,，wn.nnn.”《A"?Wwu<?’w”，,,i 
Left Lateral Left Lateral Supine Sittuig Sitting Handgrip Recovery 
(1 niin) to Supine exercise 
(5inin) (2min) |^ l^nu'n) (2min) (5n]^) 
DBP 55.5 54.5 52 57.5 59 60 60 
(nunIIg) (50-60) (46-60) (47-71) (48-87) (48-84) (44-85) (47-86) 
MAP 79.5 70.5 69 75 80.5 76.5 74.5 
(inmIIg) (65-105) (56-102) (55-92) (55-114) (58-108) (54-105) (55-115) 
Cardiac Indcx 6.2 6.1 6.6 5.6 5.4 5.2 5.4 
a>/niin/in^) (4.9-7.7) (4.2-7.4) (2.4-8.2) (4.3-6.8) (4.2-8.4) (3.5-7.4) (3.8-7.5) 
Cardiac Output 9.5 8.8 9.0 8.4 8.5 8.1 8.2 
OL/nun) (5.3-12.9) (3.5-12.4) (4.0-13.8) (4.9-11.4) (4.8-14.1) (4.5-12.4) (5.3-12.6) 
Stroke Indcx 85.3 92 95 75.7 75.7 69.3 68.4 
(ml/in2) (55.6-119) (61-125) (46-150) (46.5-113) (46.5-113) (44-101) (46-104) 
Stroke Volume 137 137 152 122 113 110 113 
(ml) (81-200) (67-210) (67-252) (68-193) (65-171) (64-173) (67-174) 
Heart Rate 74 73 76 78 79 79 80 
(beats/niin) (55-97) (50-100) (55-98) (63-100) (62-100) (65-97) (62-98) 
TPVRI 473 513 470 523 543 570 555 
(dyiie.s'.cm^ni^) (245-895) (284-1459) (258-853) (278-1276) (275-1211) (272-1301) (292-1154) 
TPVR 738 793 738 815 848 887 866 
(d>ne.s'.cni^) (418-1306) (477-2129) (407-1432) (439-1862) (470-1767) (465-1899) (460-1684) 
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ !^^ ^^ ^^ ^^ *^ *^!••••/••••*•••*•*•*•••••*•*•*•*•*•^ *•••*•*•*•***•*•*•****•^ •^•*•*•*-*•^ ***••*••***•*•*•*•*^ *•*•*•*•*•*•*•*•*•*•*^ *^•^ *•*•***•‘*•*•^ *^-••*•*•*•*•*•*•*^ *•*•*•*•*•*•*•*•••*!*••.*!*•*•*!*•*!*•*•*•**!*•  + *•••••*•*•*^ *•*•••••*•••*••••••••^ *^^ *•*••^ *•*^ ••*•*••••••••***•***•**•**^ *^•***•**•**•••*••*•*••••••••••••••__l«>*l_,__l^ "»^ «^l«»WL«>*>f>1fV\W<^ 1fVLAjVI 
i 
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In the 10 women examined eight weeks after delivery there were no 
significant changes observed in cardiac output, heart rate, diastolic blood pressure or 
total systemic vascular resistance associated with either position change or isometric 
exercise. A significant fall in MAP was observed during change of position (p=0.02) 
but this did not persist after 5 minutes rest in the supine position. No significant 
change was observed with isometric exercise. Stroke index fell significantly during 
isometric exercise (p=0.017) and the difference persisted after five minutes rest 
(p=0.037). There was no significant change in SI associated with position change 
(p=0.075). 
2.2.4.6 Relationship between platelet ANG II binding and haemodynamic 
indices. 
Spearman correlation coefficients were calculated between platelet ANG I I 
binding and each of the timed sets of measurements of haemodynamic indices. The 
highest correlation coefficients existed between ANG II binding and stroke index (r = 
-0.248: left lateral, r = -0.219: changing position, r = -0.231: supine, r = -0.230: 
during isometric exercise), and between ANG I I binding and mean arterial pressure 
measured in the left lateral position (r = -0.219). None of these relationships reached 
statistical significance however (p = 0.08). 
Figure 4.13, Figure 4.14 show the scatterplots of left lateral SI and SV 
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Table 3.6: Pregnancy Outcome. 
¾^^^ A^^^^ »^AA•^ •^M>^KSK«^»»>»*»«»、¾»¾>〜¾>^»、》^«^»»*»*»^«^»«»*•*»«»«•f^«•、^•^•n»»•‘‘、》A•»•>»‘*•»•^ «^•>•»•«•••^•l«•«•^•*•ll»•^ll«^l>•l>^>^^^«^l«^»^^^^^«^^^••气¾^ •^•••、.•»^••、•_••••、气、、•,^ .^产l、《•、•«^、•l〜气^ 、^、呼-气气•J^«^_气气^ «^ly•^气•^^ •l_f ^^•^«^_«^ _^气〜气气l^〜、气•^-仏-^«^,_f^_f•J^«lJ•^•^«^^^•^^ •^_f1_f•^J•^^ _^f^J^_f1^•^•^_P^^^_f•^f>^•^J•^J•^J•^•^•^^ «yJmy^J^m_f^y•^_f»^fy•l_f•^^ _^^ •^y•^^ J^f•^•^^ •^_f•^«^•^^^•^J^J•^f•^«^ <^•^«^^^ •^^J•^J^  
Clinical Calcium group Aspirin group Control group Normotensive PIH 
一5^ 拉9^ ?}??: (n.=.2^ (n = 2 ^ (n=12) (n = 5Q ( n = j 
Gestational 39 39 39 39 39 
age at delivery (36-41) (35-42) (38-41) (35-42) (37-4( 
(weeks) 
Birth weight of 3227 3120 3200 3200 3 0 0 0 : 
infant (2300-4050) (2470-3950) (2400-3600) (2470-4050) (2300-3( 
(gm) 
Apgar score at 9 9 10 9 9 
1 min (0-10) (3-10) (7-10) (3-10) (0-10： 
Apgar score at 10 10 10 10 10 
5 min (0-10) (7-10) (9-10) ( 9 - 1 0 ) ( 0 - 1 0 ； 
Fetal growth 1 1 1 0 1 
retardation 
Perinatal death 1 0 0 0 1 
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None of the differences between normotensive and PIH patients were statistically 
significant except birthweight (* p = 0.044). 
2.2.4.7 Pregnancy Outcome: 
Some features of clinical outcome are described in Table 3.6. Seven of the 63 
women developed PIH; three of these women developed significant proteinuria; one 
developed severe PET requiring delivery by Caesarean section. There was also one 
perinatal death, associated with intra-uterine growth retardation (birthweight 2300g 
at 37 weeks of gestation), in the PIH group: This patient was receiving calcium 
supplementation. There were no significant differences in birthweight, Apgar score or 
gestation of delivery between patients receiving low-dose aspirin, calcium 
supplementation or acting as controls. Birthweight in the PIH group was significantly 
lower than in the patients who remained normotensive (p = 0.044). 




developed PIH and those who remained normotensive for platelet ANG I I binding or 
any of the various cardiovascular indices measured. The lowest p values observed 
were for diastolic blood pressure measured in the left lateral position (p = 0.08) and 
heart rate following isometric exercise (p = 0.08). 
i I 
i 
Chapter 3 Discussion 116 
Chapter 3 
Discussion 
Study 1: Validation of Cor 7000 sphygmomanometer 
Analysis of variance with repeated measures confirms that the type of 
sphygmomanometer used has a significant influence on the actual measurements of 
blood pressure. The differences between these two machines do not influence the 
changes observed following isometric exercise (interaction between 
sphygmomanometer type and time) nor the differential changes observed between 
Pf f l categories (interaction between PIH, sphygmomanometer type and time). These 
results are as expected; the differences between these two machines merely reflecting 
different calibration rather than any inherent defect in the ability of these two 
machines to measure blood pressure changes. 
The isometric handgrip exercise test has been promoted for predicting 
patients who are destined to develop PIH (Degani et al., 1985), but, like all tests used 
in prediction, it has its critics. The changes in MAP with isometric exercise are 
dependent on tiine measured and appear to differ between patients with proteinuric 
PIH, and those who are normotensive or have only mild to moderate, non-proteinuric 
PIH. This observation, if also present in patients before the onset of clinical signs of 
PIH, may explain some of the variation in the predictive value of the isometric 
handgrip exercise test. The test is dependent on differential changes between patients 
destined to develop severe PIH and normal patients; PIH patients exhibiting a larger 
increase in pressure compared to normotensive patients. I f measurements are made 
I. 
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too early after completion ofisometric exercise the differentiation between these two 
groups will be less efficient as some normotensive patients initially demonstrate a 
large increase in pressure which subsequently decreases, and those with severe Pffl[ 
may not have reached their maximal response. From this study, testing at a period of 
2 minutes after completion of isometric exercise differentiates these patients better 
than that of 1 minute, but further research is necessary to determine the optimum 
timing in prediction before the onset of clinical signs. The advantage of continuous 
blood pressure measurement and optimum period by using the Cor 7000 is easier to 
determine than by using intermittent inflation/deflation of the cuff with the Dinamap. 
Despite the small number of patients in this study, we believe that 
discrepancies in predictive ability reported for tests such as the isometric handgrip 
exercise test will eventually be shown to relate to timing of measurement. Although 
blood pressure rises after handgrip exercise were not significantly different between 
the ipsilateral and contralateral arm, they did tend to be higher in the ipsilateral arm, 
presumably relenting specific changes induced by alteration in peripheral resistance. 
！ • 
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Study 2: Platelet ANG TT receptor status and systemic vascular resistance 
2.1. Platelet Angiotensin II binding Assay 
There is no clinical test available to accurately predict PIH. Patients with PIH 
are characterized by relatively greater blood pressure sensitivity to exogenous ANG 
I I than normotensive pregnant women. 
Baker et al (1990) showed, in 25 normotensive primigravidae, that platelet 
ANG I I binding falls in early pregnancy, with significantly lower levels in the first 
trimester (2.7 fmol/10^ cells), when compared with 25 nonpregnant women (9.0 
fmol/10^ cells, P<0.001). This is to be expected as platelets reflect changes in 
vascular smooth muscle. In our study, the results contradict those of Baker. We 
found that the median values of platelet ANG I I binding were similar in the second 
trimester of pregnancy in 63 nulliparoiis women (3.53 fmol/10^ cells,), when 
compared with 15 non-pregnant women (3.12 fmol/10^ cells, p = 0.58). Ou,r results 
suggest that the median level of platelet ANG I I binding in non-pregnant Chinese 
women is lower (3.12 fmol/10^ cells) than in Caucasian women (9.0 fmol/10^ cells: 
Baker et al). The two ethnic groups cannot be directly compared however, as some 
of the non-pregnant women tested in our study were parous, whereas all ofBaker's 
series were nulliparous. 
This may reflect some selection bias in our recruitment, or true differences in 
haemodynamic adaptation to pregnancy amongst Chinese women. 
i 
Chapter 3 Discussion 119 
Our patients were selected on the basis of raised left lateral MAP, measured 
in a research setting: on the basis of past experience, we estimate that 49% of women 
are screened-out using a cutoff value of 65 mmHg. This would be expected to 
introduce a considerable bias, as the screened out patients are by definition low risk 
and therefore would be expected (from Baker's studies) to have lower platelet ANG 
I I binding. By cutting out all patients with low MAP and low platelet ANG I I 
binding the correlation between these two variables is also reduced, and may even be 
reversed as was suggested by our data. This would also explain the lack of 
significant difference between pregnant and non-pregnant levels of ANG I I binding, 
as selected pregnant patients are more likely to have ANG I I binding close to the 
non-pregnant range. 
Although, there have been no other studies of ANG I I binding in Chinese 
pregnant women, ANG I I receptors in the feto-placental compartment have been 
studied in Japanese women. Kurauchi et al (1990) compared the ANG I I binding in 
human placenta from normal and severe pre-eclamptic pregnancies. They found no 
statistically significant difference in either the equilibrium dissociation constant (Kd) 
or the total number of placental ANG I I receptors. Knock et al, studying Caucasians, 
found significantly lower levels in patients with PIH. This suggests a racial difference 
may exist. 
The changes in ANG I I binding associated with low-dose aspirin, calcium 
supplementation and control groups are unaffected by selection bias as all three 
groups were recruited on the same basis. The randomization of the 3 groups was 
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shown to be satisfactory by the Kmskal-Wallis 1 way analyses of variance. Analysis 
of variance of platelet ANG I I binding in the third trimester revealed a significant 
difference in the low-dose aspirin group which demonstrated higher levels of binding 
than that of the other groups. Gant and associates (1987) reported that 
administration ofindomethacin or aspirin results in an increased sensitivity to infused 
ANG I I in normotensive previously ANG I I refractory women. However, this study 
used therapeutic doses of aspirin which may not be comparable to the low-dose 
mechanism. Taking all patients together, there were no significant changes 
(Wilcoxon matched pairs tests) between the second and third trimesters of 
pregnancy, platelet ANG I I binding increasing in 15 cases and decreasing in 14. 
Aspirin administration was associated with a slight increase in ANG I I receptor 
binding between the second and the third trimester in most cases, with the exception 
of two patients who had excessively high ANG I I binding (>10 fmol/109 cells). A 
similar pattern was seen in the calcium supplementation group. Unfortunately no 
control cases with excessively high platelet ANG I I binding were examined in the 
third trimester, so these effects cannot be reliably attributed to the treatments alone. 
Both low-dose aspirin (Wallenberg et al; 1991) and calcium supplementation 
(Kawasaki et al; 1994) have been shown to reduce the pressor responds to ANG I I 
infusion in the pregnant women. This reduction in vascular reactivity has been shown 
to be mediated through effects on prostinoids (Gant et al, 1987; Spitz et al, 1988; 
Caruso et al, 1991), and on PTH and renin (Cong et al 1995). Our results cannot 
confirm a consistent effect of either low-dose aspirin or calcium supplementation on 
platelet ANG II receptor binding. 
Chapter 3 Discussion 121 
This study was unable to establish whether platelet ANG I I binding has any 
predictive value for PIH in the Chinese community as two-third of the patients were 
randomized to treatments which may have prevented PIH. Since there was no 
significant difference in binding between pregnancy, puerperium or the normal non-
pregnant women, it is unlikely platelet ANG I I will prove useful in discriminating 
those at risk PIH. Assuming both low-dose aspirin and calcium supplementation 
offer some benefit in the prevention of PIH, then treatment paradox could be 
operating (Chang & Rogers 1984): the relationship between predictor and outcome 
being diminished as the poor outcome in high risk patients is prevented. 
2.2. Limitation of the TEB technique: 
This study shows unsatisfactory results for TEB. Some previous studies have 
suggested that TEB has several limitations; poor correlations between TEB and other 
established reference methods have been reported in pregnancy. 
TEB is a useful non-invasive technique for estimating CO in some clinical and 
experimental situations. It has the additional advantage of giving on-line, continuous 
measurements of cardiovascular variables. Some studies have showed that using 
Kubicek's equation to calculate CO from TEB is inappropriate. However, the 
Sramek-Bernstein equation overcomes some of the disadvantages present in the 
former equation developed by Kubicek. 
i 
i 
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In pregnancy, cardiac performance may be expressed as cardiac index in 
relation to the body surface area. However, the validity of this index as a means to 
estimate the influence of body size has been questioned in the context of other 
studies. It has been recognised that body surface area calculations using the standard 
formula are not appropriate during pregnancy and alternative corrections have been 
used since 1945 (Chesley). Recently, Carla van Oppen (1995) argued that body 
surface area in pregnancy should be determined from the weight of the subjects 
before pregnancy. This is because correction for the actual weight during pregnancy 
could introduce a greater error and would not correctly estimate the real increase in 
maternal weight. It is known that cardiac output, like other haemodynamic 
parameters, is hardly likely to remain constant from one visit to the next. In the 10 
women in our study, neither cardiac output nor body surface area returned to their 
normal values after 8 weeks post partum. 
2.3. Changes in blood pressure and other cardiovascular indices: 
Pregnancy causes substantial changes in the cardiovascular system: cardiac 
output increases by 40-50%, and blood volume by 40%, whereas systemic peripheral 
resistance and arterial pressure decrease. The changes in blood pressure observed 
following change in the position or isometric exercise vary throughout pregnancy, 
and it is not clear whether this test is more sensitive than other tests in detecting the 
onset ofPIH. 
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Position Change: Diastolic blood pressure measured in the lateral 
recumbent position is usually lower than in other positions. Naftalin et al (1978) 
found that both systolic and diastolic pressures, measured in each arm, were 
significantly higher when the subjects were supine than when they were in either left 
or right lateral positions. In our study of 63 second trimester pregnant women, there 
was a significant fall in mean arterial pressure (p=0.007) associated with position 
change from left lateral to supine, contrary to the expected rise in pressure. 
Variations in blood pressure referable to changes in diastolic blood pressure with 
posture were significantly greater amongst hypertensive than normotensive pregnant 
patients (Van Dongen et al., 1980) and were present in these pregnancies during the 
second trimester, before the onset of clinical signs (Rogers et al 1994, 1995). In our 
study, when only those patients who remained normotensive were analysed (53 
cases) the changes in blood pressure were small with MAP rising on turning from left 
lateral to supine position, as is usually the case. This observation further 
demonstrates the effect of selection bias in our sample. 
Tsonietric exercise: Isometric exercise is known to increase systemic 
arterial blood pressure in healthy adults (Lind et al., 1967). Savin et al (1980) 
observed that the blood pressure increases resulted from increased peripheral 
resistance. The results of the present non-invasive study are similes to those ofNisell 
et al (1987), who found no significant changes in CI, MAP or TPVR during isometric 
exercise. MAP did not rise significantly during the first minute of isometric handgrip 
exercise (p=0.075) in our study, but did so by the end of the second minute 
• • 
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(p<0.001), the efTect persisting throughout the recovery phase (p<0.001). This 
pattern was mimicked by that of diastolic blood pressure and TPVR; CI increased 
immediately after 5 minutes returning to pre-exercise levels. 
The change in cardiac index and MAP observed during isometric exercise was 
not significant, but both rose during the recovery phase, supporting the observation 
made during the validation study on the Cor 7000, that changes in MAP during 
isometric exercise are both time dependant and related to the presence or absence of 
PIH. 
2.4. Relationship between Platelet ANG II binding and Haemodynamic 
indices: 
The relationship between platelet ANG II binding and heamodynamic changes 
in pregnancy has not been previously reported. SI, CI, MAP and TPVR, both in the 
second trimester of pregnancy and after delivery, were compared with platelet ANG 
I I binding. CI was measured using a BoMed NCCOM3-R7 impedance cardiograph, 
which measures thoracic electrical impedance (Sramek et al, 1988). 
The study showed no significant correlations between platelet ANG I I binding 
and haemodynamic measurements. The highest correlation coefficients existed 
between ANG II binding and stroke index (left lateral: r=-0.248, changing position: 
r=-0.219 supine: r=-0.232, during isometric exercise: r=-0.23) and between ANG I I 
binding and MAP in the left lateral position (r=-0.219). Correlation coefficients 
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between platelet ANG I I binding with age (r=0.1747), height (r=0.0389), and weight 
(r=0.2379) were also not significant. Even during the postpartum period only a poor 
correlation between haemodynamic measurements (CI, SI, HR, MAP, DBP, SBP, 
TPVR) and platelet ANG 11 binding could be demonstrated. This may be due to the 
fact that body weight and cardiac index had not yet returned to preconception values 
in the 10 patients studied post-natally. 
• 




In the studies described in this thesis, the results of the Cor 7000 monitor 
provides compatible measurements to the Dinamap in pregnancy and allows 
examination of patterns of blood pressure response to isometric exercise. This 
purpose of using a mixed group of patients with and without PIH, was to extend the 
testing of the Cor 7000 across the spectrum of blood pressure measurements 
encountered in clinical practice. The isometric handgrip exercise test has been 
promoted for predicting patients who are destined to develop PIH, but, like all tests 
used in prediction, it has its critics. The advantage of continuous blood pressure 
measurement and optimum period by using the Cor 7000 is easier to determine than 
by using intermittent inflatiorVdeflation of the cuff with the Dinamap. Differential 
patterns of response may have a predictive value for proteinuric PIH. 
Secondly, the results of our second parts was not able to establish whether 
platelet ANG I I binding has any predictive value for PIH in the Chinese community. 
In our data indicate that there is no clinically relevant correlation between 
platelet ANG 11 binding and each of the timed sets of measurements of 
haemodynamic. A poor correlation were shown between platelet ANG I I binding 
and haemodynamic (CI, SI, HR, MAP, DBP, SBP, TPVR). The changes in CI and 
MAP during isometric exercise were not significant, but both rose during the 
recovery phase, it is quite clear, the pregnancy induced-hypertension is not associated 
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with enhanced cardiac responsiveness to this stimulus. So, this may help explain why 
our conclusion that the present study was unable to demonstrate that women 
suffering from PIH have abnormal cardiovascular reactivity to isometric exercise, or 
platelet ANG I I receptor. There were not associated with both relationship to this 
study. 
Our study gives little support to the notion that both low-dose aspirin and 
calcium supplementation are beneficial in women, who may be developed to PIH. 
The large study, assuming both low-dose aspirin and calcium supplementation offer 
some benefit in prevention of PIH then treatment paradox will operate. Any 
relationship between predictor and outcome will be diminished by affective 
preventative treatment. 
In the other hand, our results cannot confirm a consistent effect of either Iow-
dose aspirin or calcium supplementation on the platelet ANG I I receptor binding. 
The role of the aspirin prophylaxis is still undecided, but, low-dose aspirin favorable 
affects sensitivity to ANG II sensitive patients, thus indicating a reduced vascular 
reactivity as a consequence of this regimen. Calcium supplementation may be one 
positive role in the prevention ofhypertensive disorders of pregnancy. So, it is hoped 
that both roles shall be clarified in the future. 
In addition we have shown that the median level of platelet ANG I I binding in 
non-pregnant Chinese women have lower levels of than Caucasians, although the two 
groups are not directly comparable as some of the women tested in our study were 
parous. However, without any predictive value. 
i 
Chapter 4 Conclusion 128 
In summary, the present study confirm the preliminary findings, the urgent 
aim must be to develop screening tests which will accurately predict the patients 
destined to develop PIH. Further work in this area is needed. 
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ABSTRACT 
Objective-. To validate the Cor 7000 continuous blood pressure monitor 
for measurement of changes in blood pressure induced by isometric exercise in 
pregnancy. 
Methods: Twenty pregnant Chinese women, 9 normotensive and 11 with 
pregnancy-induced hypertension (PIH), had simultaneous brachial artery 
blootl pressure recordings performed with a Cor 7000 and a Dinamap 1846SX, 
in the supine position at rest and after isometric exercise. 
Results: Blood pressure measurements with the two machines were 
highly correlated (r > 0.8), but the Cor 7000 tended to read about 2.5 mm Hg 
lower than the Dinamap. The pattern of change in mean arterial pressure 
following isometric exercise differed between patients with proteinuric PIH 
and those who were normotensive or had only mild to moderate, nonpro-
teinuric PIH. These patterns were not influenced by the type of sphygmo-
manometer or the arm used for measurement, but the Cor 7000 tended to give 
recordings about 3 mm Hg lower than the Dinamap. 
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Conclusions: The Cor 7000 monitor provides measurements compatible 
to the Dinamap in pregnancy and allows examination of patterns of blood 
pressure response to isometric exercise. Differential patterns ofresponse may 
have a predictive value for proteinuric PIH. 
A>)’ Words: Continuous sphygmomanometry; Isometric exercise; 
Pregnancy-induced hypertension. 
INTRODUCTION 
ln clinical practice, blood pressure is measured by indirect means which most 
commonly rely on flow changes in the brachial artery following deflation of a 
pressure cuff. In recent years several automated oscillometric sphygmomanome-
ters have been introduced and have rapidly gained in popularity as they eliminate 
interobserver error. The Dinamap 1846SX (Critikon Inc., Tampa, FL) is widely 
accepted as the "gold standard" machine for use in pregnancy despite mean blood 
pressure recordings of 8 mm Hg less than conventional mercury column methods 
(1). Previous research in our unit (2,3) has been performed using the Dinamap to 
evaluate second trimester prediction of pregnancy-induced hypertension (PIH). It 
is not possible to perform beat-to-beat measurement of mean arterial pressure 
(MAP) using the Dinamap as there is no continuous digital output from the 
machine. Preliminary studies of beat-to-beat changes in cardiac output and sys-
temic vascular resistance, using a combination of the NCCOM3-R7 impedance 
cardiograph (Boined, Irving, CA) and the Finapres digital sphygmomanometer 
(Ohmeda Inc., USA) have suggested that the isometric handgrip exercise test 
causes greater changes in cardiac output than the supine pressure test (manuscript 
in preparation). While the Finapres produces a continuous output, it is subject to 
movement interference in the conscious patient. The Cor 7000 machine (Cor 
Medical Corporation, New York) continuously monitors blood pressure using a 
standard cuffplaced over the brachial artery and maintained at an inflation pressure 
of 10-20 mm Hg. Physiologic waveforms are transmitted to a transducer via 
noncompliant Uibing, where the signal is amplified. The electropneumatic system is 
designed to minimize signal-to-noise ratio to enable production of a clean, raw 
waveform signal. The normal output of the machine is analog but some minor 
modi(icalions have enabled us lo obtain a digilal output which can be downloaded 
onto a personal computer. 
We performed the following study to validate the use of the Cor 7000 in 
assessment of pregnant women by isometric handgrip exercise. 
METHODS 
Twenty patients were selected from inpatients in the antenatal ward of the 
Prince of Wales Hospital, teaching hospital of the Chinese University of Hong 
Kong. Five of these patients had a clinical diagnosis of severe, proteinuric PIH 
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(proteinuria > 300 mg/24 h or at least 24- on dipstick testing) and 6 had mild to 
moderate nonproteinuric PIH. The remainder were normotensive, with nonmedical 
conditions such as placenta praevia. None were on antihypertensive medication 
at the tiine of sludy. Hypertensive patients were included in the study in order to test 
the Cor 7000 accross the ful l range ofblood pressure measurements encountered in 
clinical practice. 
The cuff of the Cor 7000 was placed over the left brachial artery and that of 
the Dinamap over the right brachial artery. The Cor cuff was inflaled, partially 
deflated, and calibrated at a pressure between 10 and 20 mm Hg. The Dinamap was 
then activated and simultaneous diastolic, mean, and systolic blood pressure re-
cordings were recorded from both sphygmomanometers, the Cor values being 
recorded at the time the Dinamap completed its measurement cycle. Three to four 
readings were taken with both machines at 5-min intervals until the measurements 
stabilized. Isometric handgrip exercise was then performed using a grip dyna-
mometer {Takei Kik i Kogyo, Japan) at 30% of maximum for a period of 2 min 
using the left hand (Cor arm). Blood pressure recordings were performed using 
both machines 1 and 2 min after cessation of exercise. 
After a 30-min rest period, during which the cuffs were changed to opposite 
arms and blood pressure (as recorded by the Cor 7000) stabilized, the entire 
exercise was repeated, with isometric exercise being performed using the left hand 
again (Dinamap arm). 
STATISTICS 
Al l statistical analyses were performed using SPSS 6.1 for Windows. 
Blood pressure measurements performed using different sphygmomanome-
ters were compared by the Wilcoxon matched-pairs signed-ranks test, as were 
timed readings taken after isometric exercise using the same sphygmomanometer 
on different arms. Differences between pairs of measurements were compared in 
the three categories normotensive, moderate PIH, and severe proteinuric PIH by 
Kruskal -Wal l is one-way analysis of variance. Correlations between variables were 
analyzed using the Spearman correlation coefficient. 
Repeated measures analysis of variance was performed with two within-
subject variables, sphygmomanometer type and time; one between-subjects vari-
able, PIH category (normotensive, nonproteinuric PlH, and proteinuric PlH); and 
blood pressure (diastolic, mean, and systolic) as dependent variables. 
The patterns of MAP response to isometric exercise were examined graph-
ically for each of the 3 patient categories for Cor 7000 measurements performed in 
arms both contralateral and ipsilateral to that used for isometric handgrip exercise. 
RESULTS 
ln total, 477 paired (Dinamap and Cor 7000) blood pressure readings (sys-
tolic, mean, or diastolic) were performed at rest, and 240 after isometric handgrip 
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exercise. The range of recordings was from 48 to 199 mm Hg. There was no 
evidence that the Cor 7000 produce edema of the hand, the cuffremaining inflated 
for no more than 25 min at any one time. 
There were no significant differences between blood pressure measurements 
(systolic, mean, or diastolic) taken fol lowing left isometric handgrip exercise, 
when the left or right arm was used for measurement. This was true for both 
Dinamap and Cor 7000 machines. 
Figures 1(a) and 1(b) show the comparison of Dinamap and Cor readings of 
diastolic, mean, and systolic brachial artery pressures at rest and after isometric 
exercise，respectively. The readings were highly correlated (r = 0.91) for resting 
values, with slightly greater dispersion after isometric exercise (r = 0.89 at 】min， 
and r = 0.84 at 2 min after isometric exercise). The Cor 7000 tended to give lower 
readings than the Dinamap (mean difference in diastolic pressure = 1.5 mm Hg; 
mean arterial pressure = 3.6 mm Hg; systolic blood pressure = 2.3 mm Hg; overall 
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figure 1. A comparison of diastolic, mean, and systolic pressures measured by Cor 7000 and 
Dinamap 1846SX: (a) resting supine values; (b) values after isometric exercise. 
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difference = 2.5 mm Hg). The mean overall difference was 3 mm Hg for values 
recorded after isometric exercise. 
Repeated measures analysis of variance showed a significant difference 
between paired readings using the different sphygmomanometers (P = 0.009) due 
to a mean dif ference o f 4 m m Hg, the Cor 7000 tending to give higher readings than 
the Dinamap. Variation due to time was the largest factor (P < 0.0001)，with no 
significant variation due to interaction between type of sphygmomanometer and 
time of reading in relation to isometric exercise (P = 0.226) or between these two 
variables and PIH category (P 二 0.055). There was significant interaction between 
PIH category and time of measurement (P = 0.048). These results are summarized 
in Table 1. 
Tlicic was iio significant dilTcrcnce in nialenial age, height, weight, or gesta-
tional age between the normotensive and PIH groups. The differences between Cor 
7000 and Dinamap measurements were similar in all 3 PIH groups (Kruskal-Wall is 
one-way analysis of variance: not significant). 
Figures 2(a), 2(b), and 2(c) show the changes in individual M A P reading for 
each paliciit in normotensive, nonproteinuric, and proteinuric PIH patients, respec-
tively. The clilTerences in response to exercise between normotensive and PlH 
patients can be clearly seen: Normotensive women demonstrated a sharp increase 
in M A P within 1 min ofstopping isometric exercise, which stabilized or dropped (3 
out o f 9 ) by 2 min. Patients with proteinuric PIH tended to have a slower response 
to isometric exercise, 4 out of 5 patients demonstrating a continuing rise in M A P 
after 1 min, compared to only 1 oul of 6 patients with nonproteinuric PIH. The 
patterns ol response in the different PIH groups were similar when measurements 
were performed in the right or left arm (isometric handgrip exercise being per-
formed in the left arm), but blood pressure rises, at both 1 and 2 min post-isometric 
exercise, tended to be higher when measured in the left arm (Wilcoxon matched-
pairs signed-raiiks test: not significant). 
Table I. Results of Repeated Measures Analysis of Variance in Blood Pressure Measurement 
Before and After Isometric Exercise 
H O T E L L l N G ' S S IGNIFICANCE EFFECT 
EFFECT t F O F F SIZE 
PlH 1.35 3.16 0.017 0.4 
PlH by spliygnionianometer 0.39 0.9 0.506 0.16 
Sphygnionianometer 1.11 5.53 0.009 0.52 
PIH by time 2.45 2.25 0.048 0.55 
Time 8.62 17.24 0.000 0.9 
Sphygmomanometer by time 0.81 1.61 0.226 0.45 . 
PIH by sphygmomanometer by time 0.42 1.06 0.398 0.12 
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Figure 2. Individual variation in mean arterial pressures measured by Cor 7000 before and after 
isometric exercise: (a) in normotensive pregnant women; (b) in women with mild or moderate, 
nonproteinuric PIH; (c) in women with severe proteinuric PIH. 
DISCUSSION 
The number of patients used in this study was small, as the principal objective 
was to compare the Cor 7000 with the Dinamap in order to validate the former for 
use in pregnancy. The large number of paired readings (717) enables a firm 
conclusion that measurements performed using the Cor 7000 are reliable and 
broadly similar to those obtained from llie Dinamap, differing only by 2.5-3 mm 
Hg. The purpose of using a mixed group of patients, with and without PIH, was to 
extend the testing of the Cor 7()00 across the spectrum ofblood pressure measure-
ments encountered in clinical practice. 
The observations of differential response among these patient groups to 
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isometric handgrip exercise were incidental to the main aim of the study. However, 
we feel they are worthy of report as the ultiiiiale objective of validating the Cor 
7000 was lo enable its use in exploring such patterns. 
The repeated measures analysis of variance confirms that the type of sphyg-
momanometer used has a significant influence on the actual measurements ofblood 
pressure. These differences between machines do not influence the changes ob-
served fol lowing isometric exercise (interaction between sphygmomanometer type 
and lime) nor the differential changes observed between PlH categories (inter-
action between PlH, sphygmomanometer type and time). These results are as 
expected, the differences between machines merely reflecting different calibration 
rather than any inherent defect in their ability to measure blood pressure changes. 
The isometric handgrip exercise test has been promoted for predicting pa-
tients who are destined to develop PIH (4)，but, like all tests used in prediction, 
it has its critics. The changes in mean arterial pressure with isometric exercise 
appear to be lime dependent and differ between patients with proteinuric PIH and 
those who are normotensive or have only mild to moderate, nonproteinuric PIH. 
This observation, i f present in patients prior to the onset of signs of PlH, may 
explain some of the variation in the predictive value of the isometric handgrip 
exercise test. The test is dependent on differential changes between patients des-
tined to develop severe PIH and normal patients, PIH patients exhibiting a larger 
increase in pressure. I f measurements are made too early after completion of 
isometric exercise, the differentiation between groups wi l l be less efficient as some 
normotensive patients initially demonstrate a large increase in pressure which 
subsequently decreases, and those with severe PIH may not have reached their 
maximal response. For example, Ekholni et al. (5) showed diminished pressor 
responses in PIH patients compared to normotensive ones, opposite to the expected 
effect. They did not specify the timing of blood pressure measurement after 
isometric exercise but their results are similar to our 1-min values. From our study, 
a period of 2 min after completion of isometric exercise differentiates these patients 
better than 1 min, but further research is necessary to determine the optimum 
timing. This optimum period can not be determined accurately by Dinaniap as the 
infjation/dedation cycle of the cuff requires 20-30 sec. The use of the Cor 7000 for 
continuous blood pressure measurement offers a reliable alternative. 
We believe that discrepancies in predictive ability reported for tests such as 
the isonictric handgrip exercisc test wi l l eventually be shown to relate to timing of 
measureinenls. Although the blood pressure rises after exercise were not signifi-
cantly different between the ipsilateral and contralateral arm, they did tend to be 
higher in the ipsilateral arm, presumably reflecting specific changes induced by 
alteration in peripheral resistance. I l may, therefore, be advantageous to perform 
measurements in the same arni as isometric exercise in prediction studies. A larger 
study is now underway to evaluate these relationships prospectively in women with 
a second trimester pregnancy identified as being high risk for PIH, rather than those 
who already exhibit signs of disease, as in this study. 
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Key Words Abstract 
Angiotensin I I binding Objectives: The aims of this prospective study were to explore the changes in 
Aspirin platelet angiotensin I I (A-II) binding in pregnancy amongst Chinese women at 
Calcium high risk of developing pregnancy-induced hypertension (PIH) and the effects 
Mean arterial pressure, pregnancy of low-dose aspirin and calcium supplementation on A-II binding. Methods: 
Platelet angiotensin I I receptor Platelet A-II binding was assayed in 15 non-pregnant women and in 63 preg-
status, pregnancy nant women determined to be at risk of PIH on the basis of 2nd-trimester 
Pregnancy-induced hypertension mean arterial pressure (MAP). The pregnant patients were randomized into 
three groups: control, low-dose aspirin, and calcium supplementation. A-II 
binding was assayed again during the 3rd trimester in half the women and 8 
weeks after delivery. Results: A-II binding was negatively correlated with 
MAP measured in the left lateral position (p < 0.05) but not with MAP mea-
sured in the supine position. There were no significant differences between A-
I I binding in non-pregnant and pregnant women. Neither low-dose aspirin nor 
calcium supplementation caused significant reductions in A-II binding. Con-
clusions: The measurement of platelet A-II binding is unlikely to provide sig-
nificant information regarding the risk of PIH over and above that obtained 
from measurement of2nd-trimester MAP. 
Introduction tivity, with decreased binding in normotensive pregnancy 
and increased binding in pregnancies complicated by PIH 
Women with pregnancy-induced hypertension (PIH) [3]. 
are characterized by relatively greater blood pressure sen- Platelets share various characteristics with vascular 
sitivity to exogenous angiotensin I I (A-II) than normoten- smooth muscle cells and are increasingly being used as 
sive pregnant women. Evidence suggests that this is due to readily accessible models for smooth muscle cells. Ding et 
an alteration in A-II receptor sites. Ito et al. [1] have al. [4] demonstrated that platelet A-II binding is unaltered 
shown that the A-I1 sensitivity test has a similar predictive in non-pregnant subjects with essential hypertension, 
value for PIH amongst Japanese women to that reported Baker et al. [5] showed that, in normotensive primigravi-
on Caucasian subjects [2]. The A-II sensitivity test is, dae, platelet A-II binding falls in early pregnancy, with 
however, time-consuming and impractical in the clinical significantly lower levels in lst-trimester subjects when 
setting. In pregnancy, the levels of platelet A-II binding compared with non-pregnant women. Significantly higher 
have been found to mirror changes in A-II pressor sensi- (p < 0.001) levels of platelet A-II binding (up to six times 
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higher) have been found in women with proteinuric PIH Subjects and Methods 
as compared with normotens ive pr imigravidae [6, 7]. 
Th i s represents an increase in receptor number but sinii- ^ " o l s 
.^ A T| ,• ,. cc- •, n ‘• ‘1 . i、. 」, rilteen healthy, non-pregnant volunteers with regular menstrual 
l f ^ I l b ind ing affinity, refkctmg the significantly l ower〔ydcs were studied. None ofthe thcm had uscd any hormonal meth-
A-11 levels in PIH cases [7]. ods ofcontraception within the last year or were on any medication 
Baker et al. [6], s tudying the platelet A-II receptor sta- at the time ofthe study. 
tus as a predictor of P l H , concluded that downregulation 
was probably an expression of altered A-II levels. The dif- Patients 
C ^ ^ ^ „ A ^ • . „ - , , A T | u - A - U ‘ , , . A r a n d o m i z e d c o n t r o l l e d t r i a l o f p r e v e n t i o n o f P I H b y l o w - d o s e 
fe r !nce in platelet A-II b inding between pre-eclamptic aspirin or calcium supplementation, in 500 high-risk primagravidae, 
and normotensive patients was shown to precede the is under way in the Department ofObstetrics and Gynaecology ofthe 
increase in blood pressure in the former, suggesting that Chinese University of Hong Kong. The women were recruited from 
platelet A-II b inding could be used alone in predicting the the antenatal clinical at the Prince ofWales Hospital, on the basis ofa 
ou tcome o fp regnanc ies as an alternative to the A-II sensi- 'aised 2nd-trimester mean arterial pressure (MAP). The patients 
“，；“+。“ E> 1 I A \/f J , j roi r- 1 , were selected because of an initial M A P > 8 5 mm Hg (sitting, mercu-
t m t y test. Pawlak and Macdonald [8] conf i rmed receptor ,y column sphygmomanometer) at their antenatal clinicvisit be-
downregulat ion by circulating A-II in non-pregnant sub- tween 18 and 20 weeks ofgestation. Only patients who were normo-
jects but , also showed that the reduced or absent A-II tensive at booking during the 1st trimester and at the early 2nd-
binding found during the 1st tr imester of pregnancy is trimester visit were recruited. They were further screened in a 
unrelated to circulating A- I I levels. This suggests that ago- ^ a r c h setting using a Dinamap automatic oscillometric sphygmo-
.‘ ., ,j , . r * TT , . manometer in the left lateral position 9，10] between 20 and 24 
nist- induced downregulation of A-II receptors in pregnan- ^eeks ofgestation. Thc patients fulfilling the recruitment criterion of 
cy is an unlikely mechanism. These authors also demon- a resting left lateral MAP >65 mm Hg were then randomized into 
strated that patients with PIH (or who subsequently tliree groups: controls and low-dose aspirin or calcium supplementa-
developed P IH) had significantly higher levels of A-II tion. 
b inding than normotensive patients, although still below , f ^ 7 " ' f " ^ / . ' ' ' ' ' " ' ^ ' ^ from this trial for more detailed study 
‘L , 1 • , ^ , „ , . of the platelet A-II receptor status. Prior to enrollment in this study, 
the levels seen in non-pregnant controls. Several patients nature, purpose, and potential risks were explained and written 
who demonst ra ted high platelet A-II binding during the informed consent obtained from each subject. Tlie study was ap-
lst- tr imester of pregnancy developed P IH at a later stage, proved by the Ethical Committee of the Chinese University of Hong 
r a i s i n g h o p e s t h a t t h i s a s s a y c o u l d h a v e a r e a s o n a b l e p r e - Kong. The pregnant patients were all subjected to ultrasonic exami-
d i c t i v e v a l u e b e f o r e t h e o n s e t o f c l i n i c a l s igns . nation for confirmation o fps t a t i ona l ageand exclusion ofcongenital 
n , , r , i r , . , � • „ maltormation and multiple pregnancy. Venous blood (25 ml) was 
Baker et al. [6] performed serial measurements of A-II drawn at the time ofrecruitment prior to commencement oflow-dose 
binding in platelets and of plasma A-II, plasma renin sub- aspirin or calcium. All venous blood samples were obtained through 
Strate, and plasma renin concentrations throughout preg- an indwelling 19-gauge venous cannula placed in the contralateral 
nancy and puerper ium in 30 normotensive subjects. They arm to the sphygmomanometer cuff whilst resting in the semiprone 
demonstrated that a reduction in A- I I binding occurred in ^ ^ ^ ^ 7 ^ / 1 ^ ' " transferred to a tube containing trisodium 
early pregnancy and was maintained throughout, return- ^' A^U pa'tientswere followed up until after delivery to determine the 
ing to non-pregnant levels by 6 weeks after delivery. Plas- incidence of PlH and the maternal and neonatal outcomes. Tests 
m a A-II levels, plasma renin substrate and plasma renin were repeated in half the pregnant subjects between 30 and 32 weeks 
concentration all showed an inverse relationship to plate- ofgestation and in lOof these subjects between 5 and lOweeks after 
let A-II binding during pregnancy, rising to two to three delivery. 
t imes the non-pregnant levels. It is likely that these hor- Piatelet Preparation and Platelet A -II Binding Site Assay 
m o n a l p a r a m e t e r s a r e , t h e r e f o r e , a t l eas t p a r t l y r e s p o n s i - All reagents except ['^sijTyr^-A-lI were obtained from Sigma 
ble for the regulation ofA-I I binding in pregnancy. Chemical (St. Louis, Mo., USA). ['25i]Tyr4-A-II (10 nCi, 2,200 Ci/ 
M e a s u r e m e n t o f p l a t e l e t A- I I b i n d i n g is a r e l a t i v e l y mmol) was obtained from Amersham UK, and was stored in Tris-
Qt rn ioh t fnrw; i rH a w a v a n d r a n h e n e r f o r m e d m i n e a d n g l e bufTered saline (Tris 50 mniol/1 and 5 g w/v NaCI (154 mmol/l); pH 
s t i a i g h t t o r w a r d a s s a y a n d c a n b e p e r t o r m e d u s i n g a s ing l e 7 35) ^^ ^ concentration of 0.3 nmol/l. Modified medium 199 was 
venous blood sample ofapproximate ly 20 ml. added to give a solution containing 1.18 mg MgSO4, 2.54 mg CaCl2, 
This study was performed to evaluate the levels of 11.1 g glucose, 5 g EDTA and bovine serum albumin 0.5% w/v (pH 
platelet A-II binding amongst Chinese primagravidae 7.4). 
k n o w n t o b e a t h i g h r i s k o f d e v e l o p i n g P I H a n d t o d e t e r - Approximately 2.0 ml ofbIood was collected into an EDTA con-
. 1, ^ ^ r 1 • 1 . ,• , , , tainer for performing a whole blood count and platelet count using a 
m m e t h e effects of calcium supplementahon and low-dose �ouUer JTapparatus. Blood samples were collected into 10-ml slr-
a s p i r i n o n t h e s e l eve l s . stedt tubes (which had previously been sigma coated) containing 1.0 
mI trisodium citrate (3.13% w/v) and 25 mmol/1 acetylsalicylic acid 
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Table 1. Patient characteristics: ~~ 
t he s tudy inc luded 15 non-pregnan t w o m e n G r o u p N u m b e r of Age Ges ta t iona l age Weight /height 
a n d 63 n o r m o t e n s i v e w o m e n dur ing their w o m e n years weeks kg/m 
1st p regnancy . M e d i a n s with range in ~~ 
parentheses Non-pregnant 15 26 
(17 -35 ) 
Pregnant 
2nd t r imes ter 63 28 22 37.2 
(19-37) (20-24) (30.2-56.8) 
3rd t r imes ter 29 29 32 41.3 
(19-37) (28-36) (33.1-55) 
Postnata l 10 30 dclivery + 8 
(24-35) (5-10) 
T a b l e 2 . Platelet A-II binding during 
2 n d a n d 3rd t r imes ters and af te r delivery: G r o u p N u m b e r o f P l a t e l e t A - I I b i n d i n g M a n n - p 
unpaired comparison with non-pregnant women fmolA09 cells (range)a Whitney U^ 
w o m e n 
Non-prcgnant women 15 3 . 1 2 ( 0 - 1 3 . 3 9 ) 
Pregnant 
2nd t r imester 63 3 . 5 3 ( 0 - 2 8 . 9 3 ) 429 0.58 
3rd t r imester 29 5 . 4 3 ( 0 - 1 5 . 8 4 ) 162 0.17 
Postnata l 10 5 .49 (1 .19 -33 .88 ) 53 0.22 
a Platelet A-II b i n d i n g < 0 . 5 fmol/10^ cells was coded as zero. 
b Mann-Whi tney U calculated between non-pregnant controls and pregnant or postnatal 
values. 
(0.4 ml). T h e whole-blood samples were centr i fuged at 1,000 r p m for SlatisticalAnalysis 
20 min at 4 ° C to p roduce platelet-rich plasma. T h e p H value of the As platelet A-II b inding is not normally dis t r ibuted dur ing preg-
s u p e m a t a n t platelet-rich p lasma was ad jus ted to 6.4 by adding nancy, non-parametr ic statistical me thods were used for the analyses 
0.1 mol/1 citric acid (1 d rop /ml PRP) . T h e platelets were then pel- where possible, otherwise the base 10 logari thm of platelet A-II bind-
leted by centr i fugat ion at 1,500 rpm for 20 min at 4 ° C and resus- ing was used. Between-group compar i sons of platelet A-II b inding 
p e n d e d in modi f ied m e d i u m 199. T h e platelet concentra t ion in a were per formed using the Mann-Whi tney U test for two categories 
small por t ion of the suspension was measured , and the vo lume of the and Kruskal-Wallis one-way analysis of variance where more than 
m e d i u m was adjus ted to give a platelet concentra t ion of 10^ cells/^il two categories were compared . Within-group differences in platelet 
(this was measured using a platelet counter). A-II binding between the 2nd and 3rd trimester and between preg-
Platelet A-II receptor b ind ing was de te rmined as previously nant and pos tpa r tum women were tested using the Wilcoxon 
described [5]. In brief, the platelets were incubated in modif ied matched-pai rs signed-ranks test. T h e Fr iedman two-way analysis of 
m e d i u m 199 with p25l]A-II and were fur ther incubated with and variance was pe r fo rmed when more than two sets of measurements 
wi thout an excess of unlabelled A-II (25 jimol/1). The cells were incu- in the same pat ients were compared . Correlat ions between logio 
ba ted for 90 min at 2 6 ° C and then separated f rom the m e d i u m by (platelet A-II binding) and MAP, age, weight, height and weight for 
cent r i fugat ion through a mixture of phthala te esters (specific gravity height were assessed using Pearson 's correlation coefficients. 
1.03). 
Af te r incubat ing for at least 90 min, 0.1 ml o f t h e incubation mix-
ture was added to each of twelve microfuge tubes containing 0.2 ml 
of phthalate esters (dibutyl phthalate/dinonyl phthalate). All tubes Results 
were spun together at 12,000 g for 30 s in a Beckman microcentr i-
fuge. These were then frozen by immersing in liquid nitrogen. The j^o patient had a prior history ofessential hypertension 
tubes were cut with a guillotine just below the oil-medium surface, nrHinvpisriilar or resniratorv Hisea<^e nr Hia 
and both upper (medium-free) and lower (pellet-bound platelets) s e g - 沉 renal, cardiovascular, or respiratory disease or dia-
ments for each tube and were counted using a gamma counter (Cobra betes, and all were non-smokers. None of these women 
A5005 auto-mini-gamma counter). gave a history of recent usage of drugs known to influence 
90 Gynecol Obstet Invest 1996;42:88-94 Rogers/Hung/Arumanayagam 
platelet behaviour. Screening including physical examina-
tion, ful l blood count, platelet count, blood biochemistry, ^^ 
and ur ine testing was normal in all cases. Table 1 summa- R^ = 0.2940 . / 
rizes the characteristics of the women at the time of the ra / 
study. ^ / 
Pearson's correlation coefficients between logio (plate- ^ 20 / 
let A - I I binding) and maternal age, height, weight and .E . / 
body mass index were 0.297 (p = 0.022), -0.101 (p = | . . / 
0.433)，0.286 (p = 0.023), and 0.291 (p = 0.025), respec- | ‘ •• / 
tively. The correlation coefficients wi th M A P were 运 io ‘ ， . y ^ 
-0.236 (p = 0.07) for left lateral and -0.104 (p = 0.43) for | , • - • • • ^ / 
supine measurements. Figure 1 shows scatterplots of §_ i-^ <^ '— "^7；；~~*r“T—r"""*^  
platelet A- I I binding against body mass index and mater- y * \ •" , / , . . •• , • . 
nal age. °45 50 55 eo 65 70 75 8o 85 do 
Table 2 shows the platelet A-II binding for non-preg- Body mass index (kg/m^) 
nant , 2nd-tr imester , 3rd-trimester, and postnatal exami-
nat ions and compares the latter three groups with the b 
non-pregnant controls using the Mann-Whitney U test. 301 ； 
T h e median value of platelet A-II binding (fig. 2) was ^ ^ = 0.0973 
3.12 fmol/10^ cells in the non-pregnant (control) group, "| 
3.53 fmol/10^ cells in the 2nd trimester, and 5.43 fmol/ f 
109 cells in the 3rd trimester. In the 10 women studied .g 20 
after delivery, the median A- I I binding was 5.49 fmol/10^ S “ / 
cells. There was no significant difference in platelet A- I I ~ • • . 丨 . / 
binding during the 2nd or the 3rd trimester of pregnancy ^ • ‘ / 
4 J 1 Q » • / 
or during the postnatal period when compared with the ^ • ‘ , ^ ^ 
non-pregnant control group (p = 0.58, 0.17, and 0.22, | - • • ‘ * ^ J ^ , , j . - - ^ 
respectively). L ^ - ^ . — ^ - . ^ ； • 
^ ^ ^ _ , . « 參 < n * • 
Table 3 shows the paired comparison of platelet A-II p| y f ‘ _ “ . ； | • ‘ ‘ _ . ‘ ‘ . 
binding in the pregnant women between 2nd and 3rd tri- is 20 25 30 35 40 - ° ^ ^ Maternal age (years) 
mesters and between both these values and those mea-
sured 8 weeks postnatally. There were no significant dif-
ferences observed. Similarly Fr iedman two-way analysis Fig. 1. Scatterplot of 2nd-trimester platelet A-I1 binding against 
of variance of the 10 patients tested during 2nd and 3rd body mass index (a) and maternal age (b). 
trimesters of pregnancy and the puerperium showed no 
significant alterations in platelet A- I I binding (x^ = 0.6; 
p = 0.74). 
Table 4 shows the measurements of platelet A- I I bind- between the low-dose aspirin and control groups (p = 
ing in the three groups of patients before and after ran- 0.015); the low-dose aspirin group demonstrating higher 
domization into receiving calcium supplementation or platelet A- l I binding. There were insufficient cases exam-
low-dose aspirin or remaining as controls. Kruskal-Wallis ined in the puerperium to determine whether these differ-
one-way analysis of variance shows that there were no sig- ences persisted after cessation of treatment, 
nificant differences between the three groups prior to Seven patients (11.1 %) developed PIH; 3 with protein-
treatment (p = 0.369 in the 2nd trimester), but that treat- uria. 2nd trimester platelet A- I I binding was not signifi-
ment significantly altered the distribution of platelet A-I I cantly higher in these patients than in those who remained 
binding (p = 0.047 during the 3rd trimester). normotensive (p = 0.418). 
Mann-Whitney U tests showed that there was no sig-
nificant differences between the calcium supplement and 
either the low-dose aspirin (p = 0.909) or control (p = 
0.063) groups, but a significant difference was observed 
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Fig. 2 . Change in platclct A-I1 b inding � ^ ~ ^ — _ _ ^ 
b e t w e e n 2 n d a n d 3 rd t r i m e s t e r s o f p r e g n a n - Second tr i rr4i t^ T b i r d t ^ s t e r 
cy. a Low-dose aspirin group, b Calc ium 
supp lementa t ion group, c Control group. 
Discussion cental compartment have been studied in Japanese wom-
en: Kurauchi et al. [11] compared the A-II binding in 
Our findings do not support those of others. This may human placentae from normal and sevcrc prc-eclamptic 
reflect differences in haemodynamic adaptation to preg- pregnancies but found no statistically significant differ-
nancy amongst Chinese women or some selection bias in ence in either the equilibrium dissociation constant or the 
our recruitment. total number of placental A-II receptors. These authors 
There have been no previous reports on platelet A-II concluded that changes in placental A-II binding may not 
binding in Chinese women. A-II receptors in the fetopla- be involved in activation of the renin-angiotensin system 
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T a b l e 3 . Resul ts o f p l a t e l c t A-II b ind ing dur ing 2nd and 3rd t r imesters and af te r delivery: paired compar i sons 
G r o u p N u m b e r o f Platelet A-II b ind ing Wilcoxon matched-pa i r s p 
w o m e n fmol/10^ cells(range)^ s igned-rank test: Z 
Pregnant 
2nd t r imes te r 63 3 . 5 3 ( 0 - 2 8 . 9 3 ) 2nd vs. 3rd t r imester : - 0 . 2 7 0.80 
3rd i r inies ter 29 5 . 4 3 ( 0 - 1 5 . 8 4 ) 3rd t r imester vs. postnatal : - 1 . 1 7 0.24 
Pos tna ta l 10 5 . 4 9 ( 1 . 1 9 - 3 3 . 8 8 ) 2nd t r imester vs. postnatal : - 0 . 7 6 0.44 
a Platelet A-II b i n d i n g < 0 . 5 fmol/10^ cells was codcd as zcro. 
T a b l e 4 . C o m p a r i s o n o f t h c three 
g roups before and af te r r andomiza t ion to Ca lc ium Aspir in Controls y} p 
receive e i ther calc ium supplement or low-
dose aspir in or to act as controls: results of 2nd trimester 
Kruskal-Wal l is one-way analysis o f v a r i a n c e AH pat ien ts 
n 23 23 17 
Platelet A-II b inding 5.7 3.74 4.4 1.99 0.369 
Rangc 1 .06-16.9 0 - 2 8 . 9 3 1.53-9.8 
Pat ients tested dur ing both t r imesters 
n 11 9 9 
Platelet A - I I b i n d i n g 5.7 3.71 4.4 1.33 0.514 
Range 1.1-16.9 0 .25 -28 .9 1.5-9.1 
3rd trimester 
n 11 9 9 
Platelet A-II b inding 7.38 5.78 3.63 6.10 0.047 
Range 0 .57 -12 .6 3 .54-15 .84 0 - 5 . 4 9 
in severe pre-eclampsia. In contrast, Knock et al [12], be expected from Baker's studies to have lower platelet 
studying placental A-II binding in Caucasians, found sig- A-II binding. This could explain the lack of significant dif-
nificantly lower levels in patients with PIH, suggesting ferences between pregnant and non-pregnant levels of A-
that an ethnic difference may exist. We note that the I I binding, even if no ethnic difference exists. The median 
median level of platelet A-II binding in non-pregnant Chi- binding level in our 29 3rd trimester samples was 
nese women was 3.12 fmol/10^ cells as compared with 5.43 fmol/10^ cells as compared with 5.5 fmol/lO^ cells in 
9.0 fmol/109 cells in the series of Baker et al. [3]. This Baker's series of 39 women with PIH. By cutting out all 
would suggest that Chinese women have lower levels of patients with low MAP and (presumed) low platelet A-I I 
A-II binding than Caucasians, although the two groups binding, the correlation between these two variables is 
are not directly comparable, as some of the women tested reduced and may even be reversed, as suggested by our 
in our study were parous. data. 
Selection bias is likely to be responsible for some of the The changes in A-II binding associated with low-dose 
differences observed during pregnancy. Oiir patients were aspirin and calcium are unaffected by selection bias, as all 
selected on the basis ofraised left lateral MAP, measured three groups were recruited on the same basis. The ran-
in a research setting. On the basis of past experience [9, domization into the three groups was shown to be satisfac-
10], we estimate that 49% of the women are screened out tory by the Kruskal-Wallis one-way analyses of variance, 
using a cutoff value of 65 mm Hg. This would be expected Analyses of variance of platelet A-II binding during the 
to introduce a considerable bias, as the screened out 3rd trimester revealed a significant difference, with the 
patients are, by definition, low risk and therefore would low-dose aspirin group demonstrating higher levels of 
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binding than the other groups. Taking ail patients together has been shown to be mediated through effects on prosta-
there were no significant changes (Wilcoxon matched- noids [14-16] and on P T H and renin [17]. Our results 
pairs tests) between the 2nd and 3rd trimesters of preg- cannot confirm a consistent effect of either low-dose aspi-
nancy; platelet A-lI binding increasing in 15 cases and rin or of calcium supplementation on the platelet A-II 
decreasing in 14. Aspir in administration was associated receptor binding. 
with a slight increase in A-II receptor binding between This study was not able to establish whether platelet 
2nd and 3rd trimester in most cases (fig. 2a), wi th the A- I I binding has any predictive value for P IH in the Chi-
exception of 2 patients wlio had excessively high A- I I nese community, as two thirds of the patients were ran-
binding (>10 fmol/10^ cells) in whom a considerable domized to treatment groups. Assuming both low-dose 
decrease in the levels o fb ind ing was observed. A similar aspirin and calcium supplementation offer some benefit 
pat tern was observed in the calcium supplementat ion in the prevention of PIH, then t reatment paradox will 
group (fig. 2b). Unfor tunate ly no control cases with exces- operate [ 18]; any relationship between predictor and out-
sively high platelet A- I I binding were examined during come being diminished by effective preventive treatment, 
the 3rd trimester (fig. 2c), so these effects cannot be reli- However, i f neither treatment offers any benefit in pre-
ably attributed to the treatments alone. Both low-dose vention o f P I H , we can conclude that performing platelet 
aspirin [1] and calcium supplementation [13] have been A- I I binding studies offers little or no additional predic-
shown to reduce the pressor response to A-I I infusion in tive information over and above the measurement of 
pregnant women. This reduction in vascular reactivity MAP during the 2nd trimester of pregnancy. 
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